

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in the management of transient... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-1893/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-1893" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in the management of transient ischemic attacks" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in the management of transient ischemic attacks.">
            <meta name="og:description" content="Read the latest article version by Camilo R. Gomez, Michael J. Schneck, Jose&#769; Biller, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13381">
            <meta name="article-id" content="12358">
            <meta name="dc.title" content="Recent advances in the management of transient ischemic attacks">
            <meta name="dc.description" content="Significant advances in our understanding of transient ischemic attack (TIA) have taken place since it was first recognized as a major risk factor for stroke during the late 1950's. Recently, numerous studies have consistently shown that patients who have experienced a TIA constitute a heterogeneous population, with multiple causative factors as well as an average 5&ndash;10% risk of suffering a stroke during the 30 days that follow the index event. These two attributes have driven the most important changes in the management of TIA patients over the last decade, with particular attention paid to effective stroke risk stratification, efficient and comprehensive diagnostic assessment, and a sound therapeutic approach, destined to reduce the risk of subsequent ischemic stroke. This review is an outline of these changes, including a discussion of their advantages and disadvantages, and references to how new trends are likely to influence the future care of these patients.">
            <meta name="dc.subject" content="transient ischemic attack, TIA, stroke risk stratification, antiplatelet therapy, anticoagulants, arterial revascularization">
            <meta name="dc.creator" content="Gomez, Camilo R.">
            <meta name="dc.creator" content="Schneck, Michael J.">
            <meta name="dc.creator" content="Biller, Jose&#769;">
            <meta name="dc.date" content="2017/10/26">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12358.1">
            <meta name="dc.source" content="F1000Research 2017 6:1893">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="transient ischemic attack">
            <meta name="prism.keyword" content="TIA">
            <meta name="prism.keyword" content="stroke risk stratification">
            <meta name="prism.keyword" content="antiplatelet therapy">
            <meta name="prism.keyword" content="anticoagulants">
            <meta name="prism.keyword" content="arterial revascularization">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/10/26">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="1893">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12358.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-1893">
            <meta name="citation_title" content="Recent advances in the management of transient ischemic attacks">
            <meta name="citation_abstract" content="Significant advances in our understanding of transient ischemic attack (TIA) have taken place since it was first recognized as a major risk factor for stroke during the late 1950's. Recently, numerous studies have consistently shown that patients who have experienced a TIA constitute a heterogeneous population, with multiple causative factors as well as an average 5&ndash;10% risk of suffering a stroke during the 30 days that follow the index event. These two attributes have driven the most important changes in the management of TIA patients over the last decade, with particular attention paid to effective stroke risk stratification, efficient and comprehensive diagnostic assessment, and a sound therapeutic approach, destined to reduce the risk of subsequent ischemic stroke. This review is an outline of these changes, including a discussion of their advantages and disadvantages, and references to how new trends are likely to influence the future care of these patients.">
            <meta name="citation_description" content="Significant advances in our understanding of transient ischemic attack (TIA) have taken place since it was first recognized as a major risk factor for stroke during the late 1950's. Recently, numerous studies have consistently shown that patients who have experienced a TIA constitute a heterogeneous population, with multiple causative factors as well as an average 5&ndash;10% risk of suffering a stroke during the 30 days that follow the index event. These two attributes have driven the most important changes in the management of TIA patients over the last decade, with particular attention paid to effective stroke risk stratification, efficient and comprehensive diagnostic assessment, and a sound therapeutic approach, destined to reduce the risk of subsequent ischemic stroke. This review is an outline of these changes, including a discussion of their advantages and disadvantages, and references to how new trends are likely to influence the future care of these patients.">
            <meta name="citation_keywords" content="transient ischemic attack, TIA, stroke risk stratification, antiplatelet therapy, anticoagulants, arterial revascularization">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Camilo R. Gomez">
            <meta name="citation_author_institution" content="Department of Neurology, Loyola University Medical Center, Maywood, IL, USA">
            <meta name="citation_author" content="Michael J. Schneck">
            <meta name="citation_author_institution" content="Department of Neurology, Loyola University Medical Center, Maywood, IL, USA">
            <meta name="citation_author" content="Jose&#769; Biller">
            <meta name="citation_author_institution" content="Department of Neurology, Loyola University Medical Center, Maywood, IL, USA">
            <meta name="citation_publication_date" content="2017/10/26">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="1893">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12358.1">
            <meta name="citation_firstpage" content="1893">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-1893/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-1893.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13381 /> <input type=hidden id=articleId name=articleId value=12358 /> <input type=hidden id=xmlUrl value="/articles/6-1893/v1/xml"/> <input type=hidden id=xmlFileName value="-6-1893-v1.xml"> <input type=hidden id=article_uuid value=0b1c78c0-c4b8-4789-9552-69972f167c9b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in the management of transient ischemic attacks"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12358.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12358.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-1893"
  },
  "headline": "Recent advances in the management of transient ischemic attacks",
  "datePublished": "2017-10-26T14:22:51",
  "dateModified": "2017-10-26T14:22:51",
  "author": [
    {
      "@type": "Person",
      "name": "Camilo R. Gomez"
    },    {
      "@type": "Person",
      "name": "Michael J. Schneck"
    },    {
      "@type": "Person",
      "name": "Jose&#769; Biller"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Significant advances in our understanding of transient ischemic attack (TIA) have taken place since it was first recognized as a major risk factor for stroke during the late 1950's. Recently, numerous studies have consistently shown that patients who have experienced a TIA constitute a heterogeneous population, with multiple causative factors as well as an average 5&ndash;10% risk of suffering a stroke during the 30 days that follow the index event. These two attributes have driven the most important changes in the management of TIA patients over the last decade, with particular attention paid to effective stroke risk stratification, efficient and comprehensive diagnostic assessment, and a sound therapeutic approach, destined to reduce the risk of subsequent ischemic stroke. This review is an outline of these changes, including a discussion of their advantages and disadvantages, and references to how new trends are likely to influence the future care of these patients."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-1893/v1",
            "name": "Recent advances in the management of transient ischemic attacks"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in the management of transient ischemic attacks </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13381 data-id=12358 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12358.1" data-recommended="" data-doi="10.12688/f1000research.12358.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-1893/v1/pdf?article_uuid=0b1c78c0-c4b8-4789-9552-69972f167c9b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12358-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12358-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12358-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Gomez CR, Schneck MJ and Biller J. Recent advances in the management of transient ischemic attacks [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1893 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12358.1" target=_blank>https://doi.org/10.12688/f1000research.12358.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12358-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12358 id=track-article-signin-12358 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12358?target=/articles/6-1893/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13381 /> <input name=articleId type=hidden value=12358 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in the management of transient ischemic attacks</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:crgomez@lumc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Camilo R. Gomez</span></a><a href="https://orcid.org/0000-0002-8002-5157" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8002-5157</div>,&nbsp;</span><span class="">Michael J. Schneck,&nbsp;</span><span class="">Jose&#769; Biller</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:crgomez@lumc.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Camilo R. Gomez</span></a><a href="http://orcid.org/0000-0002-8002-5157" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8002-5157</div>,&nbsp;</span><span class="">Michael J. Schneck,&nbsp;</span><span class="">Jose&#769; Biller</span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 26 Oct 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12358.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Neurology, Loyola University Medical Center, Maywood, IL, USA<br/> <p> <div class=margin-bottom> Camilo R. Gomez <br/> <span>Roles: </span> Conceptualization, Data Curation, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Michael J. Schneck <br/> <span>Roles: </span> Conceptualization, Methodology, Visualization, Writing – Review & Editing </div> <div class=margin-bottom> Jose&#769; Biller <br/> <span>Roles: </span> Conceptualization, Data Curation, Methodology, Project Administration, Validation, Visualization, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27260-27153></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27261-27154></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Significant advances in our understanding of transient ischemic attack (TIA) have taken place since it was first recognized as a major risk factor for stroke during the late 1950's. Recently, numerous studies have consistently shown that patients who have experienced a TIA constitute a heterogeneous population, with multiple causative factors as well as an average 5–10% risk of suffering a stroke during the 30 days that follow the index event. These two attributes have driven the most important changes in the management of TIA patients over the last decade, with particular attention paid to effective stroke risk stratification, efficient and comprehensive diagnostic assessment, and a sound therapeutic approach, destined to reduce the risk of subsequent ischemic stroke. This review is an outline of these changes, including a discussion of their advantages and disadvantages, and references to how new trends are likely to influence the future care of these patients. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> transient ischemic attack, TIA, stroke risk stratification, antiplatelet therapy, anticoagulants, arterial revascularization </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Camilo R. Gomez (<a href="mailto:crgomez@lumc.edu">crgomez@lumc.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Camilo R. Gomez </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Gomez CR <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Gomez CR, Schneck MJ and Biller J. Recent advances in the management of transient ischemic attacks [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1893 (<a href="https://doi.org/10.12688/f1000research.12358.1" target=_blank>https://doi.org/10.12688/f1000research.12358.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 26 Oct 2017, <b>6</b>(F1000 Faculty Rev):1893 (<a href="https://doi.org/10.12688/f1000research.12358.1" target=_blank>https://doi.org/10.12688/f1000research.12358.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 26 Oct 2017, <b>6</b>(F1000 Faculty Rev):1893 (<a href="https://doi.org/10.12688/f1000research.12358.1" target=_blank>https://doi.org/10.12688/f1000research.12358.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d28076e170>Introduction</h2><p class="" id=d28076e173>The original description of TIA as a clinical entity dates back to a 1958 report by C. Miller Fisher, in which he described it as cerebral ischemic episode that "... may last from a few seconds up to several hours, the most common duration being a few seconds up to five or 10 minutes…"<sup><a href="#ref-1">1</a></sup>. Our understanding of TIAs has increased since then, with a growing realization that they represent a warning about the risk of ischemic stroke, an ominous prelude to an impending cerebrovascular catastrophe, but also the opportunity to prevent a disabling event<sup><a href="#ref-2">2</a>–<a href="#ref-5">5</a></sup>. The current definition of TIA precludes its use as a diagnosis in patients whose imaging studies display acute ischemic tissue injury (i.e. infarction), irrespective of the resolution of their symptoms<sup><a href="#ref-6">6</a></sup>. This shift from a phenomenologic to an anatomoclinical view may seem frivolous, but it underscores the importance of TIA as an opportunity for stroke prevention, much like unstable angina heralds myocardial infarction (MI) (<a href="#f1">Figure 1</a>)<sup><a href="#ref-7">7</a></sup>. This similarity is the backdrop for our discussion of the most important advances in the management of TIAs: a) improved predictive models of stroke risk (i.e. stroke risk stratification), b) optimal algorithms for evaluation (i.e. comprehensive assessment), and c) effective treatment strategies (i.e. therapeutic approach).</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure1.gif"><img alt="231594f6-44fb-41df-abe7-872d3a1580d3_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure1.gif"></a><div class=caption><h3>Figure 1. Comparison of the anatomoclinical relationship between transient ischemic attack (TIA) and cerebral infarction with the acute coronary syndromes.</h3><p id=d28076e208>TIAs can be considered the equivalent of unstable angina, with symptoms lasting for a few minutes and then abating. They often have a longer duration and an imaging counterpart (positive diffusion weighted imaging [DWI]), which may be reversible. When the ischemic process is sufficiently severe, it results in permanent injury to the brain tissue. This "ischemic continuum" mirrors the findings in acute coronary syndromes, even to the point that cerebral infarctions resulting from large arterial occlusions are emergently managed endovascularly, just like an ST-elevation myocardial infarction (STEMI), while the smaller infarctions are handled by non-interventional means, just like a non-STEMI (NSTEMI).</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28076e218>Stroke risk stratification</h2><div class=section><a name=d28076e221 class=n-a></a><h3 class=section-title>Etiopathogenic variability</h3><p class="" id=d28076e226>Unlike unstable angina, TIAs can result from very different causative factors, each with its own particular risk profile<sup><a href="#ref-8">8</a>,<a href="#ref-9">9</a></sup>. Therefore, the care of patients with TIA requires etiopathogenic evaluation and individualized estimation of their stroke risk. It seems intuitive that if a) TIA is to be considered the warning (i.e. a "threat" or "alarm") of an impending ischemic stroke and b) its assigned stroke risk depends on its pathogenic process, prevention strategies should match stroke subtype. Stroke subtype classification is best carried out by applying the scheme designed for the Trial of ORG-10172 in Acute Stroke Treatment (TOAST)<sup><a href="#ref-8">8</a></sup>. Unfortunately, the likelihood of correctly identifying stroke subtype in the emergency department (ED) approximates 60%, making it impractical for use before patients are fully evaluated<sup><a href="#ref-10">10</a></sup>.</p><p class="" id=d28076e244>Thus, although the risk of stroke following a TIA is estimated at 5–10%, and despite 15–20% of ischemic stroke patients reporting a premonitory TIA, their etiopathogenic heterogeneity and inherent variability of stroke risk is illustrated by each patient profile<sup><a href="#ref-4">4</a>,<a href="#ref-11">11</a>–<a href="#ref-13">13</a></sup>. This has led to the development of various scoring systems for stroke risk stratification<sup><a href="#ref-2">2</a>–<a href="#ref-5">5</a>,<a href="#ref-7">7</a>,<a href="#ref-11">11</a>,<a href="#ref-12">12</a>,<a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>, all striving to satisfy the following attributes: a) ability to discriminate between high and low stroke risk, b) consistency of performance across clinical scenarios<sup><a href="#ref-15">15</a></sup>, and c) rapid applicability, since time is of the essence in the ED<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a>,<a href="#ref-5">5</a>,<a href="#ref-7">7</a>,<a href="#ref-11">11</a>,<a href="#ref-12">12</a>,<a href="#ref-14">14</a></sup>.</p></div><div class=section><a name=d28076e308 class=n-a></a><h3 class=section-title>Stroke risk scoring systems</h3><p class="" id=d28076e313>The scoring systems from the 1990's were concerned with long-term stroke risk<sup><a href="#ref-16">16</a>–<a href="#ref-21">21</a></sup>. Later, increasing appreciation of TIA as a medical emergency led to interest in quantifying short-term risk and early stroke prevention<sup><a href="#ref-3">3</a>,<a href="#ref-22">22</a>–<a href="#ref-30">30</a></sup>. The first wave of scoring systems, including the California Risk Score (CRS)<sup><a href="#ref-3">3</a></sup>, ABCD<sup><a href="#ref-30">30</a></sup>, and ABCD<sup>2</sup><sup><a href="#ref-27">27</a></sup>, comprised stroke risk factors (i.e. age, blood pressure, and diabetes mellitus) and semiologic variables (i.e. clinical features and duration of symptoms) (<a href="#T1">Table 1</a>). The CRS showed progressively higher scores to be associated with an increasing proportion of stroke events adjudicated during a 90-day follow up period but did not include a final stratification into a high- and low-risk dichotomy<sup><a href="#ref-3">3</a></sup>. The ABCD (i.e. age, blood pressure, clinical features, and duration of symptoms) score adjudicated no stroke events with ABCD scores &lt;4, while the 7-day risk of stroke increased to 35.5% with ABCD scores &gt;6<sup><a href="#ref-30">30</a></sup>. In another population, ABCD scores &lt;2 were associated with no 30-day stroke events, the risk progressively increasing with higher scores, reaching 31.3% in patients with ABCD scores of 6<sup><a href="#ref-31">31</a></sup>. The most significant finding was an 8-fold increase with ABCD ≥5<sup><a href="#ref-31">31</a></sup>, suggesting the presence of a "tipping point" at which stroke risk increases exponentially. The introduction of the ABCD score was rapidly embraced by the community of vascular neurologists and has provided the seminal platform for the introduction of progressively more complex scoring systems. The combination of the CRS and the ABCD scores resulted in the ABCD<sup>2</sup> score, which stratified three different risk groups as low (&lt;4), moderate (4–5), and high (6–7) risk<sup><a href="#ref-27">27</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Comparison of the different stroke risk scoring systems used in patients with transient ischemic attack (TIA).</h3><p id=d28076e385>See text and <a href="#f2">Figure 2</a> for additional information. CIP, clinical imaging-based prediction; CRS, California Risk Score; DBP, diastolic blood pressure; DWI, diffusion weight imaging; SBP, systolic blood pressure.</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28076e392 class=n-a></a><thead><a name=d28076e394 class=n-a></a><tr><a name=d28076e396 class=n-a></a><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e398 class=n-a></a>System</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e401 class=n-a></a>Semiologic Variables</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e404 class=n-a></a>Risk<br class=br>Factors</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e409 class=n-a></a>Imaging<br class=br>Findings</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e414 class=n-a></a>Score</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e418 class=n-a></a>% Stroke Risk<br class=br>(Period)</th></tr></thead><tbody><a name=d28076e425 class=n-a></a><tr><a name=d28076e427 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e429 class=n-a></a>CRS<br class=br>(2000)<sup><a href="#ref-3">3</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e437 class=n-a></a>Duration &gt;10 minutes<br class=br>Weakness<br class=br>Speech Impairment</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e444 class=n-a></a>Age &gt;60<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e449 class=n-a></a>N/A</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e452 class=n-a></a>1<br class=br>2<br class=br>3<br class=br>4<br class=br>5</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e464 class=n-a></a>3<br class=br>7<br class=br>11<br class=br>15<br class=br>34<br class=br>(90 day)</td></tr><tr><a name=d28076e478 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e480 class=n-a></a>ABCD<br class=br>(2005)<sup><a href="#ref-30">30</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e488 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e495 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e502 class=n-a></a>N/A</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e505 class=n-a></a>1–3<br class=br>4<br class=br>5<br class=br>6</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e515 class=n-a></a>0<br class=br>2.2<br class=br>16.3<br class=br>35.5<br class=br>(7 day)</td></tr><tr><a name=d28076e527 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e529 class=n-a></a>ABCD2<br class=br>(2007)<sup><a href="#ref-27">27</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e537 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e544 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e553 class=n-a></a>N/A</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e556 class=n-a></a>1–3<br class=br>4–5<br class=br>6–7</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e564 class=n-a></a>1.0<br class=br>4.1<br class=br>8,1<br class=br>(2 day)</td></tr><tr><a name=d28076e574 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e576 class=n-a></a>ABCD2 + MRI<br class=br>(2007)<sup><a href="#ref-23">23</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e584 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e591 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e600 class=n-a></a>+DWI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e603 class=n-a></a>1–4<br class=br>5–6<br class=br>7–9</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e611 class=n-a></a>0<br class=br>5.4<br class=br>32.1<br class=br>(90 day)</td></tr><tr><a name=d28076e621 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e623 class=n-a></a>CIP<br class=br>(2009)<sup><a href="#ref-22">22</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e631 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e638 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e647 class=n-a></a>+DWI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e650 class=n-a></a>&gt;3<br class=br>+DWI<br class=br>&gt;3 &amp; +DWI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e658 class=n-a></a>2.0<br class=br>4.9<br class=br>14.9<br class=br>(7 day)</td></tr><tr><a name=d28076e669 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e671 class=n-a></a>ABCD2-I<br class=br>(2010)<sup><a href="#ref-26">26</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e679 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e686 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e695 class=n-a></a>+DWI or +CT</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e698 class=n-a></a>1–2<br class=br>3<br class=br>4<br class=br>5<br class=br>6<br class=br>7<br class=br>8<br class=br>9<br class=br>10</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e719 class=n-a></a>0<br class=br>1.2<br class=br>1.6<br class=br>2.0<br class=br>3.7<br class=br>4.0<br class=br>12.3<br class=br>15.1<br class=br>12.2<br class=br>(7 day)</td></tr><tr><a name=d28076e742 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e744 class=n-a></a>ABCD3<br class=br>(2010)<sup><a href="#ref-28">28</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e752 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e759 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes<br class=br>Recent TIA</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e770 class=n-a></a>N/A</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e773 class=n-a></a>1–3<br class=br>4–5<br class=br>6–9</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e781 class=n-a></a>1<br class=br>2<br class=br>6<br class=br>(90 day)</td></tr><tr><a name=d28076e791 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e793 class=n-a></a>ABCD3-I<br class=br>(2010)<sup><a href="#ref-28">28</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e801 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e808 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes<br class=br>Recent TIA</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e819 class=n-a></a>+DWI or<br class=br>carotid<br class=br>stenosis</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e826 class=n-a></a>1–3<br class=br>4–7<br class=br>8–13</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e834 class=n-a></a>1<br class=br>2<br class=br>8<br class=br>(90 day)</td></tr><tr><a name=d28076e844 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e846 class=n-a></a>ABCDE⊕<br class=br>(2010)<sup><a href="#ref-25">25</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e854 class=n-a></a>Weakness<br class=br>Speech<br class=br>Duration<br class=br>Etiology</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e863 class=n-a></a>Age &gt;60<br class=br>SBP &gt;140 mmHg or<br class=br>DBP &gt;90 mmHg<br class=br>Diabetes</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e872 class=n-a></a>+DWI</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e875 class=n-a></a>1–3<br class=br>4<br class=br>5<br class=br>6<br class=br>7<br class=br>8<br class=br>9<br class=br>10<br class=br>11<br class=br>12</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e898 class=n-a></a>0<br class=br>7<br class=br>15<br class=br>3<br class=br>17<br class=br>20<br class=br>28<br class=br>24<br class=br>18<br class=br>25<br class=br>(90 day)</td></tr></tbody></table></div><p class="" id=d28076e926>However, the predictability of these scores was not optimal and they only partially fulfilled the criteria outlined earlier. Concurrently, abnormal diffusion weighted imaging (DWI) on magnetic resonance imaging (MRI) was found to correlate with stroke risk<sup><a href="#ref-32">32</a>,<a href="#ref-33">33</a></sup>. Thus, the addition of a DWI-positive point to the ABCD<sup>2</sup> score resulted in a system whose tiers had different 90-day stroke risks (i.e. 0% for scores &lt;4 and up to 32.1% for scores of 7–9) and, additionally, different 90-day risks for functional impairment, an outcome not measured by the original ABCD<sup>2</sup> score<sup><a href="#ref-23">23</a></sup>. Imaging-related stratification improvement has been replicated using two other systems, the clinical imaging-based prediction (CIP) model<sup>22</sup> and the ABCD<sup>2</sup>-I<sup><a href="#ref-26">26</a></sup>.</p><p class="" id=d28076e957>The next wave of scoring systems improved the predictability of stroke risk by including diagnostic information as it became available<sup><a href="#ref-28">28</a></sup>. The ABCD<sup>3</sup> added the occurrence of a TIA within the preceding week to the ABCD<sup>2</sup> score, but the results were disappointing<sup><a href="#ref-28">28</a></sup>. However, the same group added two more imaging variables (i.e. DWI lesions and carotid stenosis) to the ABCD<sup>3</sup> model, showing that ABCD<sup>3</sup>-I was superior to previous scores in predicting stroke at 7, 28, and 90 days<sup><a href="#ref-28">28</a></sup>. A similar approach to stroke risk stratification involved the Alberta Stroke Prevention in TIAs and Mild Strokes (ASPIRE) intervention, which assigned a high-risk denomination to patients with a) ABCD<sup>2</sup> scores ≥4, b) motor or speech symptoms lasting &gt;5 minutes, or c) atrial fibrillation (AF)<sup><a href="#ref-24">24</a></sup>. However, ASPIRE allocated over three-quarters of patients to the high-risk category, cancelling out the benefit of triaging TIA patients.</p><p class="" id=d28076e993>The most recent initiative involves the addition of "etiology" to an algorithm that already includes all the variables listed above<sup><a href="#ref-25">25</a></sup>. The ABCDE⊕ scoring system was designed by adding two variables to the ABCD score: a) "etiology", which included a point-weighting of each particular stroke subtype based on published data<sup><a href="#ref-34">34</a></sup>, and b) "DWI-positivity", which consisted of arbitrarily assigning three points to a positive MRI based on inferential conclusions from published data<sup><a href="#ref-25">25</a>,<a href="#ref-35">35</a></sup>. Setting an arbitrary boundary of &gt;6 points to designate high-risk patients, this system compared favorably with both ABCD<sup>2</sup> (i.e. statistically significant) and ABCD (i.e. trend only) in identifying TIA patients at high risk for stroke (<a href="#T1">Table 1</a>)<sup><a href="#ref-25">25</a></sup>.</p></div><div class=section><a name=d28076e1023 class=n-a></a><h3 class=section-title>Perspective and practical approach to stroke risk prediction</h3><p class="" id=d28076e1028>Stroke risk stratification of patients with TIA, reliably identifying those more likely to benefit from urgent intervention, is a subject of considerable importance in vascular neurology. At the bedside, it is useful to approach stroke risk stratification by systematically considering the three domains that include the variables that comprise the scoring systems described (<a href="#f2">Figure 2</a>): a) risk factors (i.e. age, hypertension, diabetes, AF, and previous TIA), b) semiologic variables (i.e. type of symptoms and signs and duration of deficit), and c) imaging findings (i.e. DWI lesions, carotid stenosis, and etiology).</p><p class="" id=d28076e1034>In applying a domain-driven approach to stroke risk assessment, it is possible to simultaneously address the components of all of the scoring systems described without actually being bound by any one of them at the expense of others. It can be argued that the disadvantage is that it may not be possible to equate every single clinical scenario with a numerical prediction of stroke risk. On the other hand, arriving at a numerical representation of the stroke risk does not seem to be as important as identifying which patients have a greater than minimal risk, a clinical task that requires the expert formulation of a more qualitative view of the patient as an individual<sup><a href="#ref-36">36</a>–<a href="#ref-43">43</a></sup>. This approach seems supported by existing experience in comparing the simultaneous application of the various stroke risk scoring systems. Recent reports by a European consortium of vascular neurology investigators, the "Proyecto Español del Manejo y Evaluación de los Pacientes con un Ataque Isquémico Transitorio" (PROMAPA), underscore the importance of going beyond the scoring systems, particularly in unstable patients and those with recurrent TIAs<sup><a href="#ref-29">29</a>,<a href="#ref-44">44</a></sup>.</p><p class="" id=d28076e1051>The limitation of the various scoring systems is not surprising when considering that a) the boundaries between the various levels of stroke risk have been set arbitrarily, b) some variables are better defined than others (e.g. blood pressure is defined as &gt;140 mmHg systolic and/or &gt;90 mmHg diastolic but, at which point? How many measurements does it take?), and c) the point weighting of some variables (e.g. imaging) has been derived from previous, often not replicated studies. In addition, in many clinical scenarios where TIA patients are seen for the first time, much of the information required for scoring diagnostic variables is not available, and only the simpler of the scoring systems are applicable.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure2.gif"><img alt="231594f6-44fb-41df-abe7-872d3a1580d3_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure2.gif"></a><div class=caption><h3>Figure 2. Variables that compose the different stroke risk scoring systems.</h3><p id=d28076e1064>Three domains are used to group the components contained within the different stroke risk scoring systems. The earlier systems (i.e. California Risk Score [CRS], “age, blood pressure, clinical features, and duration of symptoms” [ABCD], and ABCD<sup>2</sup>) only included components from the “risk factors” and “semiologic variables” domains. The more recent ones (i.e. ABCD<sup>2</sup>-MRI, clinical imaging-based prediction [CIP], ABCD<sup>2</sup>-I, ABCD<sup>3</sup>-I, and ABCDE⊕), shown to have better predictability, added one or more components from the “imaging findings” domain.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28076e1087>Comprehensive assessment</h2><p class="" id=d28076e1090>The diagnostic evaluation of TIAs revolves around the determination of the cause and mechanism of the index event. In addition, as TIA is a medical emergency worthy of urgent management, diagnostic investigations require an efficient and expedited algorithm.</p><div class=section><a name=d28076e1093 class=n-a></a><h3 class=section-title>Timing and location</h3><p class="" id=d28076e1098>A major topic of debate involves when, where, and how to evaluate TIA patients most effectively. The typical patient presents <i>after</i> the symptoms of the index event have abated, creating two conflictive considerations: a) the inconvenience and discomforts of hospitalizing a neurologically normal patient and b) the inherent risks of a protracted ambulatory evaluation<sup><a href="#ref-45">45</a>–<a href="#ref-50">50</a></sup>. Opinions regarding the best approach are sharply divided<sup><a href="#ref-51">51</a></sup>, with the proponents of an ambulatory workflow citing "cost-effectiveness" and better "resource utilization" as their main arguments<sup><a href="#ref-47">47</a>,<a href="#ref-52">52</a>,<a href="#ref-53">53</a></sup>. Conversely, those who favor an in-hospital process argue for "expediency of care", "patient safety", and better outcomes<sup><a href="#ref-46">46</a>,<a href="#ref-48">48</a>,<a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup>. The most recent literature on this subject is, at best, inconclusive; both approaches have advantages and disadvantages based on two sets of variables: a) the patient's stroke risk profile and b) the clinical environment construct and capabilities. The former has been covered in the previous sections, but the latter is worthy of further discussion.</p><p class="" id=d28076e1138>Traditionally, TIA patients present to the ED because of extensive educational campaigns consistently instructing them to "DIAL 9-1-1" upon recognition of stroke symptoms. They are then admitted for "23-hour observation" while their evaluation is completed. The benefits of this approach include a) patients have a captive audience of medical personnel who watch over them in case of a neurologic change, b) the results of the diagnostic tests are known almost immediately and can be used in real time to update the stroke risk calculation, c) the identification of a need for urgent therapeutic intervention allows rapid execution of any treatment plan, and d) there is little risk of suffering an ischemic stroke while waiting to have the tests completed (including results review) or to "fall through the cracks" because of scheduling mishaps. Experts agree that this approach is appropriate when managing high-risk TIA patients<sup><a href="#ref-54">54</a></sup> but question whether it is justified for those at low risk<sup><a href="#ref-47">47</a>,<a href="#ref-51">51</a></sup>. Unfortunately, low scores do not necessarily translate into low stroke risk, particularly in the ED. In fact, approximately 20% of patients with ABCD<sup>2</sup> &lt;4 harbor either an atherosclerotic or a cardiogenic source of stroke and 3-month stroke risk comparable to those with scores &gt;4<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d28076e1159>A recently introduced alternative environment for the evaluation of TIA patients is the TIA clinic (<a href="#f3">Figure 3</a>)<sup><a href="#ref-51">51</a>,<a href="#ref-55">55</a>–<a href="#ref-57">57</a></sup>, whose demonstrated effectiveness and beneficial impact on outcome<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup> depend on the following attributes:</p><p class="" id=d28076e1182>a) <span style="text-decoration: underline">Fast track access</span>: referral of potential TIA patients must unequivocally result in immediate appointments<sup><a href="#ref-51">51</a>,<a href="#ref-53">53</a>–<a href="#ref-57">57</a></sup>. It is unreasonable to consider TIA as an emergency and simultaneously subject the patient to the inherent delays of ambulatory care. Thus, the established metrics are appointments made within 24 hours for high-risk patients and within 48 hours for others<sup><a href="#ref-59">59</a>–<a href="#ref-61">61</a></sup>.</p><p class="" id=d28076e1206>b) <span style="text-decoration: underline">Specialist (i.e. vascular neurologist) assessment</span>: there is simply no substitute for experience. The diagnosis of TIA can be challenging<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>, as many other conditions may "mimic" its presentation<sup><a href="#ref-64">64</a>–<a href="#ref-71">71</a></sup>. Moreover, its identification must be followed by a cerebrovascular localization diagnosis, which has a direct impact on the etiopathogenic assessment and stroke subtype diagnosis<sup><a href="#ref-72">72</a></sup>. Only a specialist in cerebrovascular disorders can rightfully prioritize the diagnostic and therapeutic needs of a TIA patient (<a href="#f3">Figure 3</a>)<sup><a href="#ref-73">73</a>,<a href="#ref-74">74</a></sup>.</p><p class="" id=d28076e1241>c) <span style="text-decoration: underline">Rapid access to diagnostic investigations</span>: once a patient is evaluated by a specialist, diagnostic investigations must be carried out very quickly (<a href="#f3">Figure 3</a>). Such a workflow can be challenging, particularly when competing for time slots or when, in the case of transesophageal echocardiography (TEE), another specialist's participation is required. Once completed, the vascular neurologist must have rapid access to the results in order to be able to make the next set of decisions (<a href="#f3">Figure 3</a>).</p><p class="" id=d28076e1253>d) <span style="text-decoration: underline">Multidisciplinary network</span>: there must be access to a variety of consultants from other disciplines, particularly cardiologists, neurosurgeons, and vascular surgeons. This implies that these specialists are also available at a moment's notice to evaluate the patient (<a href="#f3">Figure 3</a>).</p><p class="" id=d28076e1262>e) <span style="text-decoration: underline">Educational programs</span>: patients must be educated in relevant topics, such as stroke risk factors and their management, beneficial lifestyle changes, and interventions (i.e. medications and procedures) used in the prevention of stroke.</p><div class="fig panel clearfix"><a name=f3 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure3.gif"><img alt="231594f6-44fb-41df-abe7-872d3a1580d3_figure3.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/13381/231594f6-44fb-41df-abe7-872d3a1580d3_figure3.gif"></a><div class=caption><h3>Figure 3. Optimal workflow in a transient ischemic attack (TIA) clinic.</h3><p id=d28076e1278>A potential TIA patient is referred to the clinic and his visit with the vascular neurologist is expedited (lightning bolt). Upon assessment, if the patient is found not to have had a TIA, his care is diverted to an alternative clinical pathway. If the vascular neurologist determines that the patient has had a TIA, he can proceed by immediately requesting the appropriate diagnostic procedures. Test completion and results reporting are also expedited (lightning bolt), allowing the vascular neurologist to quickly review them and decide on a treatment strategy tailored to the patient's risk profile. Management includes patient and family education as well as appropriate referral to pre-specified specialists.</p></div></div></div><div class=section><a name=d28076e1286 class=n-a></a><h3 class=section-title>Depth of diagnostic evaluation</h3><p class="" id=d28076e1291>The battery of diagnostic tests required for TIA evaluation is geared at uncovering the cause and mechanism (i.e. stroke subtype classification) of the index event. Most TIA patients fall into either the large artery atherothromboembolic (~30–40% of cases) or the cardiogenic (~15–20%) categories (i.e. TOAST)<sup><a href="#ref-75">75</a></sup>, the two subtypes that pose the greatest stroke risk following TIA<sup><a href="#ref-34">34</a></sup>. Therefore, the priorities of such diagnostic evaluation involve examination of the cerebral arterial system<sup><a href="#ref-76">76</a>,<a href="#ref-77">77</a></sup> and a search for cardiogenic sources of embolization<sup><a href="#ref-78">78</a>–<a href="#ref-86">86</a></sup>. Other tests (e.g. coagulation studies), although certainly important, are easier to carry out, only infrequently lead to positive findings, and rarely carry a sense of urgency.</p><p class="" id=d28076e1316>The cerebral vasculature can be evaluated noninvasively with magnetic resonance angiography (MRA), computed tomography angiography (CTA), or neurovascular ultrasound (i.e. extracranial carotid and vertebral color Doppler and transcranial Doppler ultrasound). The choice of which to use depends on a) the clinical scenario, b) the specific vascular pathology suspected, and c) the imaging resources available at any particular clinical site. One advantage of MRA is that it can be completed concurrently with MRI, which is the stroke imaging technique of choice<sup><a href="#ref-35">35</a>,<a href="#ref-75">75</a>,<a href="#ref-76">76</a>,<a href="#ref-87">87</a>–<a href="#ref-92">92</a></sup> and a component of several stroke risk scoring systems<sup><a href="#ref-22">22</a>–<a href="#ref-26">26</a></sup>. However, CTA has also been shown to be useful in the early assessment of TIA<sup><a href="#ref-93">93</a></sup> as well as for patients who cannot undergo MRI. Patients with renal insufficiency who cannot receive contrast (either iodinated or gadolinium-based) can often only be evaluated using ultrasound. When noninvasive cerebrovascular imaging is inconclusive or when it indicates pathology that requires intervention, cerebral catheterization and angiography remains an important tool for evaluation and treatment selection<sup><a href="#ref-94">94</a>,<a href="#ref-95">95</a></sup>. Although cerebral angiography is invasive and certainly with some risks, the information obtained from this technique is often not available by any other means.</p><p class="" id=d28076e1353>As for cardiogenic TIA, the introduction of TEE represents a major diagnostic advancement due to a) increased resolution and sensitivity for left atrial pathology, including the left atrial appendage and the interatrial septum, and b) capability for imaging the aortic arch, uncovering the presence of complex atherosclerotic plaques as a source of artery-to-artery cerebral embolism<sup><a href="#ref-80">80</a>–<a href="#ref-82">82</a>,<a href="#ref-84">84</a>,<a href="#ref-85">85</a></sup>. Finally, the detection of occult paroxysmal AF in patients with unexplained events correlates with the length of the cardiac rhythm assessment<sup><a href="#ref-86">86</a></sup>, improved by 7- to 30-day cardiac event monitors<sup><a href="#ref-96">96</a>–<a href="#ref-101">101</a></sup> and even more so by implantable loop recorders<sup><a href="#ref-83">83</a>,<a href="#ref-97">97</a>–<a href="#ref-99">99</a>,<a href="#ref-101">101</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28076e1397>Therapeutic strategies</h2><div class=section><a name=d28076e1400 class=n-a></a><h3 class=section-title>General measures</h3><p class="" id=d28076e1405>Despite the significant risk of stroke during the first week following a TIA<sup><a href="#ref-3">3</a>,<a href="#ref-4">4</a>,<a href="#ref-12">12</a>,<a href="#ref-102">102</a></sup>, stroke prevention can be optimized (i.e. stroke risk reduction of ~80%) by rapid and intensive interventions<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a>,<a href="#ref-103">103</a></sup>. Undoubtedly, tailoring therapeutic measures to the specific etiopathogenic mechanism (i.e. stroke subtype) is the most desirable strategy. However, since such assessment cannot be made with certainty in the ED<sup><a href="#ref-10">10</a></sup>, the immediate management of patient presentation should be viewed as part of a continuum, with certain specific measures (e.g. antiplatelet therapy) possible with minimal risk and potentially significant benefit as soon as the first CT scan is reviewed<sup><a href="#ref-104">104</a>–<a href="#ref-107">107</a></sup>.</p><p class="" id=d28076e1442>Some general measures of care don't even require any imaging to be completed for their implementation. For example, isotonic crystalloid solutions can easily be administered to TIA patients as soon as they arrive in the ED. Not only is this inexpensive and low-risk step in line with the existing guidelines for the early management of acute ischemic stroke<sup><a href="#ref-108">108</a></sup> but it also addresses the fact that approximately 50% of stroke patients present with measurable dehydration<sup><a href="#ref-109">109</a>–<a href="#ref-115">115</a></sup>. Along the same lines, any patient with TIA should be given "best medical management" of oxygenation, careful blood pressure control, and serum glucose regulation, just as if they had suffered a <i>bona fide</i> ischemic stroke<sup><a href="#ref-108">108</a></sup>.</p></div><div class=section><a name=d28076e1464 class=n-a></a><h3 class=section-title>Target-specific measures</h3><p class="" id=d28076e1469><b><i>Antiplatelet therapy</i>.</b> Early antithrombotic therapy leads to about 80% relative reduction of stroke risk in patients with TIA, although the best strategy continues to be a matter of debate<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>. In general, aspirin has been thought to reduce the odds of a subsequent stroke by approximately 20–25% in patients with previous TIA or stroke<sup><a href="#ref-116">116</a></sup> and doses of 50–325 mg per day continue to be recommended due to their lower risk of hemorrhagic side effects<sup><a href="#ref-117">117</a></sup>. There is increasing evidence, however, that aspirin is the key interventional step in reducing the early risk of stroke following TIA, with yields of 60% overall relative risk reduction and 70% reduction of disabling or fatal strokes<sup><a href="#ref-103">103</a></sup>. In parallel, the Fast Assessment of Stroke and Transient Ischemic Attack to prevent Early Recurrence (FASTER) trial provided evidence that aspirin plus clopidogrel may be substantially beneficial in the hyperacute treatment of patients with TIA<sup><a href="#ref-118">118</a></sup>. Similar results were reported by the Clopidogrel with Aspirin in Acute Minor Stroke of Transient Ischemic Attack (CHANCE) study<sup><a href="#ref-119">119</a></sup>, with benefit that persisted at one year of follow up<sup><a href="#ref-120">120</a></sup>. Another ongoing trial with a similar aim, the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) study, has already recruited about 80% of its target sample size and results should be available within 18–24 months<sup><a href="#ref-121">121</a></sup>. Patients with large artery atherosclerosis<sup><a href="#ref-8">8</a></sup> have been shown by several studies to benefit from double antiplatelet therapy<sup><a href="#ref-118">118</a>,<a href="#ref-122">122</a>,<a href="#ref-123">123</a></sup>. That said, more is not necessarily better, and the recently reported (not yet published) Triple Antiplatelets for Reducing Dependency after Ischemic Stroke (TARDIS) study failed to show a benefit of adding dipyridamole to aspirin and clopidogrel for stroke risk reduction<sup><a href="#ref-124">124</a>,<a href="#ref-125">125</a></sup>. The results of TARDIS are not surprising since, although shown to be beneficial in combination with low-dose aspirin<sup><a href="#ref-126">126</a>,<a href="#ref-127">127</a></sup>, dipyridamole has not been found to be superior to clopidogrel in reducing the risk of stroke<sup><a href="#ref-128">128</a></sup>.</p><p class="" id=d28076e1545>In the last few years, there has been considerable interest in the study of other antiplatelet agents for secondary stroke prevention<sup><a href="#ref-129">129</a>–<a href="#ref-133">133</a></sup>. Cilostazol, an agent similar to dipyridamole, has been shown in two Asian studies to be superior to aspirin in reducing vascular events in patients with stroke, with the caveat that those results may not be applicable to other populations. The SOCRATES study showed ticagrelor, a PY2 inhibitor similar to clopidogrel, to be approximately 30% more effective than and equally as safe as aspirin in reducing major adverse events in patients with TIA and atherosclerotic stenosis<sup><a href="#ref-129">129</a>–<a href="#ref-132">132</a></sup>.</p><p class="" id=d28076e1562><b><i>Anticoagulants</i>.</b> Vitamin K antagonists, namely warfarin, have been in use for many years, and their main applications have been in patients with AF, mechanical heart valve prostheses, and other causes of cardiogenic brain embolism. In patients with non-valvular AF (NVAF), warfarin reduces the risk of stroke by approximately 67% in comparison to no treatment and by 37% when compared with antiplatelet therapy<sup><a href="#ref-134">134</a></sup>. The indications for warfarin in other scenarios of cardiac dysfunction are less clearly supported by the literature but reasonable to consider on an individual basis: a) severe left atrial enlargement (LAE), particularly those with spontaneous echo contrast<sup><a href="#ref-135">135</a>–<a href="#ref-143">143</a></sup>, b) abnormally low flow in the left atrial appendage (LAA)<sup><a href="#ref-144">144</a>–<a href="#ref-147">147</a></sup>, and c) left ventricular (LV) dysfunction<sup><a href="#ref-148">148</a>–<a href="#ref-153">153</a></sup>.</p><p class="" id=d28076e1594>Recently, two other classes of oral anticoagulants for the treatment of patients with NVAF have become available (<a href="#T2">Table 2</a>): direct thrombin (i.e. dabigatran)<sup><a href="#ref-154">154</a>–<a href="#ref-158">158</a></sup> and factor Xa (i.e. apixaban<sup><a href="#ref-159">159</a>–<a href="#ref-164">164</a></sup>, rivaroxaban<sup><a href="#ref-165">165</a></sup>, and edoxaban<sup><a href="#ref-166">166</a>,<a href="#ref-167">167</a></sup>) inhibitors. These medications have all been successfully tested against warfarin in patients with NVAF, and their appeal is based on the fact that they have shorter half-lives, fewer drug and food interactions, and do not require laboratory therapeutic monitoring<sup><a href="#ref-154">154</a>–<a href="#ref-167">167</a></sup>. Presently, only dabigatran has a specifically designated reversing agent (i.e. idarucizumab – Praxbind®)<sup><a href="#ref-168">168</a></sup>, a fact that adds a unique dimension to its use. Unfortunately, the use of these new anticoagulants is not without its own set of problems. For instance, they are all excreted via the kidneys, so care must be exercised in their use in patients with renal insufficiency<sup><a href="#ref-160">160</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Comparison of the principal trials that have studied the new generation of anticoagulants.</h3><p id=d28076e1652>See text for more detailed information. ARISTOTLE, Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVERROES, Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment; BID, bis in die; CHADS2, congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke (double weight); ENGAGE AF, Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation; RE-LY, Randomized Evaluation of Long-Term Anticoagulation Therapy; ROCKET AF, Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation; TIA, transient ischemic attack.</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28076e1656 class=n-a></a><thead><a name=d28076e1658 class=n-a></a><tr><a name=d28076e1660 class=n-a></a><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1662 class=n-a></a>Drug</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1665 class=n-a></a>Dabigatran<br class=br>(110 mg BID)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1670 class=n-a></a>Dabigatran<br class=br>(150 mg BID)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1675 class=n-a></a>Apixaban<br class=br>(5 mg BID)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1680 class=n-a></a>Apixaban<br class=br>(5 mg BID)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1686 class=n-a></a>Rivaroxaban<br class=br>(20 mg daily)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e1691 class=n-a></a>Edoxaban<br class=br>(60 mg daily)</th></tr></thead><tbody><a name=d28076e1698 class=n-a></a><tr><a name=d28076e1700 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1702 class=n-a></a><b>Trial</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1706 class=n-a></a>RE-LY<sup><a href="#ref-154">154</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1712 class=n-a></a>RE-LY<sup><a href="#ref-154">154</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1718 class=n-a></a>AVERROES<sup><a href="#ref-159">159</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1724 class=n-a></a>ARISTOTLE<sup><a href="#ref-161">161</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1731 class=n-a></a>ROCKET-AF<sup><a href="#ref-165">165</a></sup></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1737 class=n-a></a>ENGAGE-AF<sup><a href="#ref-166">166</a></sup></td></tr><tr><a name=d28076e1744 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1746 class=n-a></a><b>Mean age (years)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1750 class=n-a></a>71.4</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1753 class=n-a></a>71.5</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1756 class=n-a></a>70</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1759 class=n-a></a>70</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1763 class=n-a></a>73</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1766 class=n-a></a>72</td></tr><tr><a name=d28076e1770 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1772 class=n-a></a><b>Mean CHADS2</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1776 class=n-a></a>2.1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1779 class=n-a></a>2.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1782 class=n-a></a>2.0</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1785 class=n-a></a>2.1</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1789 class=n-a></a>3.5</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1792 class=n-a></a>2.8</td></tr><tr><a name=d28076e1796 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1798 class=n-a></a><b>Previous</b><br class=br><b>TIA/stroke (%)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1805 class=n-a></a>20</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1808 class=n-a></a>20</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1811 class=n-a></a>14</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1814 class=n-a></a>19</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1818 class=n-a></a>55</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1821 class=n-a></a>28.1</td></tr><tr><a name=d28076e1825 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1827 class=n-a></a><b>Mean time in target</b><br class=br><b>range (%)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1834 class=n-a></a>64</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1837 class=n-a></a>64</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1840 class=n-a></a>N/A</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1843 class=n-a></a>62</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1847 class=n-a></a>58</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1850 class=n-a></a>68.4</td></tr><tr><a name=d28076e1855 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1857 class=n-a></a><b>Rate of stroke/</b><br class=br><b>embolism (%/year)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1864 class=n-a></a>1.5 v. 1.69</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1867 class=n-a></a>1.11 v. 1.69</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1870 class=n-a></a>1.6 v. 3.7</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1873 class=n-a></a>1.27 v. 1.60</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1877 class=n-a></a>1.7 v. 2.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1880 class=n-a></a>1.18 v. 1.50</td></tr><tr><a name=d28076e1884 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1886 class=n-a></a><b>Rate of major</b><br class=br><b>bleeding (%/year)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1893 class=n-a></a>2.71 v. 3.36</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1896 class=n-a></a>3.11 v. 3.36</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1899 class=n-a></a>1.4 v. 1.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1902 class=n-a></a>2.13 v. 3.09</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1906 class=n-a></a>3.6 v. 3.4</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1909 class=n-a></a>2.75 v. 3.43</td></tr><tr><a name=d28076e1913 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1915 class=n-a></a><b>Mortality from any</b><br class=br><b>cause (%/year)</b></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1922 class=n-a></a>3.75 v. 4.13</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1925 class=n-a></a>1.9 v 2.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1928 class=n-a></a>3.5 v. 4.4</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1931 class=n-a></a>3.52 v. 3.94</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1935 class=n-a></a>1.9 v. 2.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e1938 class=n-a></a>3.99 v. 4.35</td></tr></tbody></table></div><p class="" id=d28076e1945>Successful anticoagulation of patients with AF depends on careful benefit versus risk assessment. This is aided by available scoring systems, namely the CHA<sub>2</sub>DS<sub>2</sub>-VASc score<sup><a href="#ref-169">169</a>,<a href="#ref-170">170</a></sup> (i.e. a "second generation" improvement of the original CHAD<sub>2</sub> score<sup><a href="#ref-171">171</a></sup>) to determine stroke risk and the HAS-BLED score to quantify risk of hemorrhagic complications (<a href="#T3">Table 3</a>)<sup><a href="#ref-172">172</a></sup>. Scoring allows characterization of yearly risks along stepwise progressive scales, which can then be easily compared for the purposes of clinical decisions<sup><a href="#ref-169">169</a>,<a href="#ref-170">170</a>,<a href="#ref-172">172</a></sup>. Typically, calculation of the HAS-BLED score requires more attention to detail, since its components have been more precisely defined<sup><a href="#ref-172">172</a></sup>. For example, while in CHA<sub>2</sub>DS<sub>2</sub>-VASc the "H" stands for "hypertension" as an active diagnosis<sup><a href="#ref-169">169</a></sup>, in the HAS-BLED the "H" stands for "uncontrolled hypertension" (i.e. &gt;160 mmHg systolic)<sup><a href="#ref-172">172</a></sup>. Moreover, the original definition does not specify over what period, but it seems reasonable that, in order to contribute to the bleeding risk, the blood pressure would have to be persistently elevated. Consequently, not only is a single measurement insufficient to assign a point but, practically, aggressive blood pressure control should reduce the HAS-BLED score (<a href="#T3">Table 3</a>).</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Comparison of the two scoring systems most commonly used to assess benefit versus risk of anticoagulation in patients with non-valvular atrial fibrillation.</h3><p id=d28076e2018><span style="text-decoration: underline">HAS-BLED definitions<sup><a href="#ref-171">171</a></sup></span>:</p><p id=d28076e2026>Hypertension = <i>"'Uncontrolled hypertension' as evidenced by &gt;160 mmHg systolic."</i></p><p id=d28076e2031>Abnormal renal function = <i>"Chronic dialysis, renal transplantation, or serum creatinine ≥200 μmol/L"</i></p><p id=d28076e2036>Abnormal liver function = <i>"Chronic hepatic disease (e.g. cirrhosis) or biochemical evidence of significant hepatic derangement (e.g. bilirubin &gt;2Xupper limit normal, and so forth."</i></p><p id=d28076e2042>Stroke = <i>"Previous history, particularly lacunar"</i></p><p id=d28076e2047>Bleeding history or predisposition = <i>"Any bleeding requiring hospitalization and/or causing a decrease in haemoglobin level &gt;2 g/L and/or requiring blood transfusion that was not a hemorrhagic stroke"</i></p><p id=d28076e2052>Labile international normalized ratio (INR) = <i>"Therapeutic time in range &lt;60%"</i></p><p id=d28076e2057>Elderly = <i>"&gt;65 years"</i></p><p id=d28076e2062>Drugs = <i>"Antiplatelet agents, non-steroidal anti-inflammatory drugs"</i></p><p id=d28076e2067>Alcohol excess= <i>"≥8 units alcoholic consumption per week"</i></p><p id=d28076e2073>AP, angina pectoris; LVD, left ventricular dysfunction; MI, myocardial infarction; PVD, peripheral vascular disease; TE, thromboembolism; TIA, transient ischemic attack.</p></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d28076e2077 class=n-a></a><thead><a name=d28076e2079 class=n-a></a><tr><a name=d28076e2081 class=n-a></a><th align=center colspan=2 rowspan=1 valign=top><a name=d28076e2083 class=n-a></a>CHA2DS2-VASc<sup><a href="#ref-169">169</a></sup></th><th align=center colspan=2 rowspan=1 valign=top><a name=d28076e2089 class=n-a></a>HAS-BLED<sup><a href="#ref-172">172</a></sup></th></tr><tr><a name=d28076e2096 class=n-a></a><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e2098 class=n-a></a>Criteria [POINTS]</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e2101 class=n-a></a>Stroke &amp; TE Risk (% Yearly)</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e2104 class=n-a></a>Criteria [POINTS]</th><th align=center colspan=1 rowspan=1 valign=top><a name=d28076e2107 class=n-a></a>Bleeding Risk (% Yearly)</th></tr></thead><tbody><a name=d28076e2112 class=n-a></a><tr><a name=d28076e2114 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2116 class=n-a></a> <span style="text-decoration: underline"><b>C</b></span>ongestive heart failure/LVD [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2123 class=n-a></a>1...................1.3</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2126 class=n-a></a><span style="text-decoration: underline"><b>H</b></span>ypertension [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2132 class=n-a></a>1...................1.02</td></tr><tr><a name=d28076e2136 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2138 class=n-a></a><span style="text-decoration: underline"><b>H</b></span>ypertension [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2144 class=n-a></a>2...................2.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2147 class=n-a></a><span style="text-decoration: underline"><b>A</b></span>bnormal renal [1] or liver [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2153 class=n-a></a>2...................1.88</td></tr><tr><a name=d28076e2157 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2159 class=n-a></a><span style="text-decoration: underline"><b>A</b></span>ge ≥ 75 years [2]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2165 class=n-a></a>3...................3.2</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2168 class=n-a></a><span style="text-decoration: underline"><b>S</b></span>troke [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2174 class=n-a></a>3...................3.74</td></tr><tr><a name=d28076e2178 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2180 class=n-a></a><span style="text-decoration: underline"><b>D</b></span>iabetes mellitus [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2186 class=n-a></a>4...................4.0</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2189 class=n-a></a><span style="text-decoration: underline"><b>B</b></span>leeding [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2195 class=n-a></a>4...................8.70</td></tr><tr><a name=d28076e2199 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2201 class=n-a></a><span style="text-decoration: underline"><b>S</b></span>troke/TIA/TE [2]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2207 class=n-a></a>5...................6.7</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2210 class=n-a></a><span style="text-decoration: underline"><b>L</b></span>abile INRs [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2216 class=n-a></a>5...................12.5</td></tr><tr><a name=d28076e2221 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2223 class=n-a></a><span style="text-decoration: underline"><b>V</b></span>ascular disease (MI, PVD, AP) [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2229 class=n-a></a>6...................9.8</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2232 class=n-a></a><span style="text-decoration: underline"><b>E</b></span>lderly [1]</td><td colspan=1 rowspan=1><a name=d28076e2238 class=n-a></a></td></tr><tr><a name=d28076e2241 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2243 class=n-a></a><span style="text-decoration: underline"><b>A</b></span>ge 65–74 years [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2249 class=n-a></a>7...................9.6</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2252 class=n-a></a><span style="text-decoration: underline"><b>D</b></span>rugs [1] or alcohol excess [1]</td><td colspan=1 rowspan=1><a name=d28076e2258 class=n-a></a></td></tr><tr><a name=d28076e2261 class=n-a></a><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2263 class=n-a></a><span style="text-decoration: underline"><b>S</b></span>ex <span style="text-decoration: underline"><b>c</b></span>ategory (female) [1]</td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2273 class=n-a></a>7...................6.7</td><td colspan=1 rowspan=1><a name=d28076e2276 class=n-a></a></td><td colspan=1 rowspan=1><a name=d28076e2278 class=n-a></a></td></tr><tr><a name=d28076e2281 class=n-a></a><td colspan=1 rowspan=1><a name=d28076e2283 class=n-a></a></td><td align=center colspan=1 rowspan=1 valign=top><a name=d28076e2285 class=n-a></a>9...................15.2</td><td colspan=1 rowspan=1><a name=d28076e2288 class=n-a></a></td><td colspan=1 rowspan=1><a name=d28076e2290 class=n-a></a></td></tr></tbody></table></div><p class="" id=d28076e2296><b><i>Arterial revascularization</i>.</b> There is a robust body of knowledge to indicate that patients who have experienced a TIA due to an ipsilateral carotid atherosclerotic stenosis of more than 50% benefit from revascularization either by carotid endarterectomy (CEA)<sup><a href="#ref-173">173</a>,<a href="#ref-174">174</a></sup> or by carotid artery stenting (CAS)<sup><a href="#ref-174">174</a>–<a href="#ref-177">177</a></sup>. Either procedure should be carried out as soon as it is practical, preferably within two weeks of the index event<sup><a href="#ref-174">174</a>,<a href="#ref-178">178</a></sup>, by expert teams, in centers that perform a high volume of procedures, and with a track record of a major complicating event rate of &lt;6%<sup><a href="#ref-174">174</a>,<a href="#ref-178">178</a></sup>.</p><p class="" id=d28076e2331>In patients with TIA and extracranial vertebral artery stenosis, despite the existing literature<sup><a href="#ref-179">179</a>–<a href="#ref-181">181</a></sup>, the guidelines suggest that stenting be reserved for patients who remain "symptomatic" despite optimal medical therapy, including risk factor modification and antithrombotic agents<sup><a href="#ref-174">174</a></sup>. The recommendation for patients with intracranial atherosclerosis, even those with severe stenosis, is that they are managed with maximal medical therapy<sup><a href="#ref-174">174</a></sup>, based on the results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) study<sup><a href="#ref-182">182</a>,<a href="#ref-183">183</a></sup>. Although it is beyond the scope of our review to undermine the SAMMPRIS study, we must indicate the number of criticisms made of its design and execution<sup><a href="#ref-184">184</a>–<a href="#ref-188">188</a></sup> and suggest that additional study of this subject is needed.</p><p class="" id=d28076e2363><b><i>Vascular risk factor modification</i>.</b> Blood pressure control is recommended to reduce the risk of stroke in patients with TIA<sup><a href="#ref-174">174</a></sup>. The desirable blood pressure is uncertain in the few hours that follow the index event, when a "normal" level may aggravate ischemia because of abnormal autoregulation or upstream pressure gradients. Subsequently, blood pressure should be reduced to &lt;140/90 mmHg in most patients and &lt;130/80 mmHg in diabetics<sup><a href="#ref-174">174</a></sup>.</p><p class="" id=d28076e2379>Intensive lipid-lowering therapy with statins should be instituted in patients with atherosclerosis and low-density lipoprotein cholesterol (LDL-C) &gt;100 mg/dL<sup><a href="#ref-174">174</a></sup>. Moreover, early use of statins has been shown to benefit patients with TIA without causing undue adverse events<sup><a href="#ref-189">189</a>–<a href="#ref-191">191</a></sup>, although not uniformly (e.g. the FASTER study failed to show any benefit from simvastatin)<sup><a href="#ref-118">118</a></sup>. An exciting prospect is the introduction of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors which, when added to statins, seem to result in a more effective reduction of LDL-C<sup><a href="#ref-192">192</a>,<a href="#ref-193">193</a></sup>, with potential beneficial effect in stroke risk reduction<sup><a href="#ref-194">194</a>–<a href="#ref-199">199</a></sup>.</p><p class="" id=d28076e2411>Diabetes and the metabolic syndrome have been associated with an increased risk of stroke<sup><a href="#ref-200">200</a></sup>. Patients with TIA should be screened for diabetes by means of hemoglobin A1c (HbA1c) and for obesity by measuring the body mass index (BMI)<sup><a href="#ref-174">174</a></sup>. In the future, it may be possible to predict insulin resistance in non-diabetic TIA patients by means of scoring systems<sup><a href="#ref-201">201</a></sup>. Recent data suggest that abnormal glycemic control may also have a negative effect on the efficacy of clopidogrel<sup><a href="#ref-202">202</a></sup>, and glucose reduction through diet, exercise, oral hypoglycemic agents, and insulin to a fasting &lt;126 mg/dL is recommended<sup><a href="#ref-174">174</a></sup>. The pharmacologic choices for achieving glucose control are numerous and their application depends on different clinical considerations. However, in the recently published Insulin Resistance Intervention after Stroke (IRIS) study, pioglitazone was shown to reduce the risk of stroke and MI by approximately 24% in patients with recent TIA<sup><a href="#ref-203">203</a></sup>.</p><p class="" id=d28076e2439>In addition to all of the previous recommendations, patients must be counselled about smoking cessation, proper diet (preferably Mediterranean), regular exercise, maintenance of appropriate BMI, and limiting alcohol consumption as measures that require their own active participation to reduce their risk of subsequent stroke<sup><a href="#ref-174">174</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d28076e2450>Conclusion</h2><p class="" id=d28076e2453>The diagnosis of a TIA represents the recognition of a medical emergency and an opportunity to reduce the risk of stroke by decisively evaluating the patient and applying any combination of the currently available therapeutic strategies. The future is likely to show additional methods of early diagnosis, better algorithms for stroke risk stratification, and enhanced systems of care for these patients, without a dependence on hospitalization.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d28076e1 class=n-a></a><h2 class=main-title id=d28677>Competing interests</h2><p class=metadata-entry><a name=d28076e105 class=n-a></a><p id=d28076e107> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d28076e1 class=n-a></a><h2 class=main-title id=d28679>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d28076e2460 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d29321>References</h2><div class="section ref-list"><a name=d28076e2460 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d28076e2467 class=n-a></a>Fisher CM: Intermittent Cerebral Ischemia. In: Wright ISM CH, ed. <i>Cerebral Vascular Disease</i>. New York: Grune &amp; Stratton, 1958; 81–97. </span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d28076e2479 class=n-a></a>Chandratheva A, Mehta Z, Geraghty OC, <i> et al.</i>: Population-based study of risk and predictors of stroke in the first few hours after a TIA. <i>Neurology.</i> 2009; <b>72</b>(22): 1941–7. <a target=xrefwindow id=d28076e2490 href="http://www.ncbi.nlm.nih.gov/pubmed/19487652">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2493 href="http://dx.doi.org/10.1212/WNL.0b013e3181a826ad">Publisher Full Text </a> | <a target=xrefwindow id=d28076e2497 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2690971">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d28076e2506 class=n-a></a>Johnston SC, Gress DR, Browner WS, <i> et al.</i>: Short-term prognosis after emergency department diagnosis of TIA. <i>JAMA.</i> 2000; <b>284</b>(22): 2901–6. <a target=xrefwindow id=d28076e2517 href="http://www.ncbi.nlm.nih.gov/pubmed/11147987">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2520 href="http://dx.doi.org/10.1001/jama.284.22.2901">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d28076e2529 class=n-a></a>Lisabeth LD, Ireland JK, Risser JM, <i> et al.</i>: Stroke risk after transient ischemic attack in a population-based setting. <i>Stroke.</i> 2004; <b>35</b>(8): 1842–6. <a target=xrefwindow id=d28076e2540 href="http://www.ncbi.nlm.nih.gov/pubmed/15192239">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2543 href="http://dx.doi.org/10.1161/01.STR.0000134416.89389.9d">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d28076e2552 class=n-a></a>Wu CM, McLaughlin K, Lorenzetti DL, <i> et al.</i>: Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. <i>Arch Intern Med.</i> 2007; <b>167</b>(22): 2417–22. <a target=xrefwindow id=d28076e2563 href="http://www.ncbi.nlm.nih.gov/pubmed/18071162">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2566 href="http://dx.doi.org/10.1001/archinte.167.22.2417">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d28076e2576 class=n-a></a>Sacco RL, Kasner SE, Broderick JP, <i> et al.</i>: An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke.</i> 2013; <b>44</b>(7): 2064–89. <a target=xrefwindow id=d28076e2587 href="http://www.ncbi.nlm.nih.gov/pubmed/23652265">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2590 href="http://dx.doi.org/10.1161/STR.0b013e318296aeca">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d28076e2599 class=n-a></a>Uchiyama S: The concept of acute cerebrovascular syndrome. <i>Front Neurol Neurosci.</i> 2014; <b>33</b>: 11–8. <a target=xrefwindow id=d28076e2607 href="http://www.ncbi.nlm.nih.gov/pubmed/24157553">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2610 href="http://dx.doi.org/10.1159/000351888">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d28076e2619 class=n-a></a>Adams HP Jr, Bendixen BH, Kappelle LJ, <i> et al.</i>: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. <i>Stroke.</i> 1993; <b>24</b>(1): 35–41. <a target=xrefwindow id=d28076e2630 href="http://www.ncbi.nlm.nih.gov/pubmed/7678184">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2633 href="http://dx.doi.org/10.1161/01.STR.24.1.35">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d28076e2642 class=n-a></a>Amarenco P, Bogousslavsky J, Caplan LR, <i> et al.</i>: New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke. <i>Cerebrovasc Dis.</i> 2009; <b>27</b>(5): 502–8. <a target=xrefwindow id=d28076e2653 href="http://www.ncbi.nlm.nih.gov/pubmed/19342826">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2656 href="http://dx.doi.org/10.1159/000210433">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d28076e2665 class=n-a></a>Madden KP, Karanjia PN, Adams HP Jr, <i> et al.</i>: Accuracy of initial stroke subtype diagnosis in the TOAST study. Trial of ORG 10172 in Acute Stroke Treatment. <i>Neurology.</i> 1995; <b>45</b>(11): 1975–9. <a target=xrefwindow id=d28076e2676 href="http://www.ncbi.nlm.nih.gov/pubmed/7501144">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2679 href="http://dx.doi.org/10.1212/WNL.45.11.1975">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d28076e2688 class=n-a></a>Giles MF, Rothwell PM: Transient ischaemic attack: clinical relevance, risk prediction and urgency of secondary prevention. <i>Curr Opin Neurol.</i> 2009; <b>22</b>(1): 46–53. <a target=xrefwindow id=d28076e2696 href="http://www.ncbi.nlm.nih.gov/pubmed/19155761">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2699 href="http://dx.doi.org/10.1097/WCO.0b013e32831f1977">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d28076e2709 class=n-a></a>Giles MF, Rothwell PM: Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. <i>Lancet Neurol.</i> 2007; <b>6</b>(12): 1063–72. <a target=xrefwindow id=d28076e2717 href="http://www.ncbi.nlm.nih.gov/pubmed/17993293">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2720 href="http://dx.doi.org/10.1016/S1474-4422(07)70274-0">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d28076e2729 class=n-a></a>Brainin M, McShane LM, Steiner M, <i> et al.</i>: Silent brain infarcts and transient ischemic attacks. A three-year study of first-ever ischemic stroke patients: the Klosterneuburg Stroke Data Bank. <i>Stroke.</i> 1995; <b>26</b>(8): 1348–52. <a target=xrefwindow id=d28076e2740 href="http://www.ncbi.nlm.nih.gov/pubmed/7631335">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2743 href="http://dx.doi.org/10.1161/01.STR.26.8.1348">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d28076e2752 class=n-a></a>Rothwell PM, Warlow CP: Timing of TIAs preceding stroke: time window for prevention is very short. <i>Neurology.</i> 2005; <b>64</b>(5): 817–20. <a target=xrefwindow id=d28076e2760 href="http://www.ncbi.nlm.nih.gov/pubmed/15753415">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2763 href="http://dx.doi.org/10.1212/01.WNL.0000152985.32732.EE">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d28076e2772 class=n-a></a>Giles MF, Rothwell PM: Systematic review and pooled analysis of published and unpublished validations of the ABCD and ABCD2 transient ischemic attack risk scores. <i>Stroke.</i> 2010; <b>41</b>(4): 667–73. <a target=xrefwindow id=d28076e2780 href="http://www.ncbi.nlm.nih.gov/pubmed/20185786">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2783 href="http://dx.doi.org/10.1161/STROKEAHA.109.571174">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d28076e2792 class=n-a></a>Kernan WN, Horwitz RI, Brass LM, <i> et al.</i>: A prognostic system for transient ischemia or minor stroke. <i>Ann Intern Med.</i> 1991; <b>114</b>(7): 552–7. <a target=xrefwindow id=d28076e2803 href="http://www.ncbi.nlm.nih.gov/pubmed/2001088">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2806 href="http://dx.doi.org/10.7326/0003-4819-114-7-552">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d28076e2815 class=n-a></a>Hankey GJ, Slattery JM, Warlow CP: Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events? <i>J Neurol Neurosurg Psychiatr.</i> 1992; <b>55</b>(8): 640–52. <a target=xrefwindow id=d28076e2823 href="http://www.ncbi.nlm.nih.gov/pubmed/1527533">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2826 href="http://dx.doi.org/10.1136/jnnp.55.8.640">Publisher Full Text </a> | <a target=xrefwindow id=d28076e2829 href="http://www.ncbi.nlm.nih.gov/pmc/articles/489198">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d28076e2839 class=n-a></a>CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. <i>Lancet.</i> 1996; <b>348</b>(9038): 1329–39. <a target=xrefwindow id=d28076e2847 href="http://www.ncbi.nlm.nih.gov/pubmed/8918275">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2850 href="http://dx.doi.org/10.1016/S0140-6736(96)09457-3">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d28076e2859 class=n-a></a>Kernan WN, Viscoli CM, Brass LM, <i> et al.</i>: The stroke prognosis instrument II (SPI-II) : A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. <i>Stroke.</i> 2000; <b>31</b>(2): 456–62. <a target=xrefwindow id=d28076e2870 href="http://www.ncbi.nlm.nih.gov/pubmed/10657422">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2873 href="http://dx.doi.org/10.1161/01.STR.31.2.456">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d28076e2882 class=n-a></a>van Wijk I, Kappelle LJ, van Gijn J, <i> et al.</i>: Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. <i>Lancet.</i> 2005; <b>365</b>(9477): 2098–104. <a target=xrefwindow id=d28076e2893 href="http://www.ncbi.nlm.nih.gov/pubmed/15964446">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2896 href="http://dx.doi.org/10.1016/S0140-6736(05)66734-7">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d28076e2905 class=n-a></a>Weimar C, Benemann J, Michalski D, <i> et al.</i>: Prediction of recurrent stroke and vascular death in patients with transient ischemic attack or nondisabling stroke: a prospective comparison of validated prognostic scores. <i>Stroke.</i> 2010; <b>41</b>(3): 487–93. <a target=xrefwindow id=d28076e2916 href="http://www.ncbi.nlm.nih.gov/pubmed/20056932">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2919 href="http://dx.doi.org/10.1161/STROKEAHA.109.562157">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d28076e2928 class=n-a></a>Ay H, Arsava EM, Johnston SC, <i> et al.</i>: Clinical- and imaging-based prediction of stroke risk after transient ischemic attack: the CIP model. <i>Stroke.</i> 2009; <b>40</b>(1): 181–6. <a target=xrefwindow id=d28076e2939 href="http://www.ncbi.nlm.nih.gov/pubmed/18948609">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2942 href="http://dx.doi.org/10.1161/STROKEAHA.108.521476">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d28076e2951 class=n-a></a>Coutts SB, Eliasziw M, Hill MD, <i> et al.</i>: An improved scoring system for identifying patients at high early risk of stroke and functional impairment after an acute transient ischemic attack or minor stroke. <i>Int J Stroke.</i> 2008; <b>3</b>(1): 3–10. <a target=xrefwindow id=d28076e2962 href="http://www.ncbi.nlm.nih.gov/pubmed/18705908">PubMed Abstract </a> | <a target=xrefwindow id=d28076e2965 href="http://dx.doi.org/10.1111/j.1747-4949.2008.00182.x">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d28076e2975 class=n-a></a>Coutts SB, Sylaja PN, Choi YB, <i> et al.</i>: The ASPIRE approach for TIA risk stratification. <i>Can J Neurol Sci.</i> 2011; <b>38</b>(1): 78–81. <a target=xrefwindow id=d28076e2986 href="http://www.ncbi.nlm.nih.gov/pubmed/21156434">PubMed Abstract </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d28076e2995 class=n-a></a>Engelter ST, Amort M, Jax F, <i> et al.</i>: Optimizing the risk estimation after a transient ischaemic attack - the ABCDE⊕ score. <i>Eur J Neurol.</i> 2012; <b>19</b>(1): 55–61. <a target=xrefwindow id=d28076e3006 href="http://www.ncbi.nlm.nih.gov/pubmed/21554497">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3009 href="http://dx.doi.org/10.1111/j.1468-1331.2011.03428.x">Publisher Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d28076e3018 class=n-a></a>Giles MF, Albers GW, Amarenco P, <i> et al.</i>: Addition of brain infarction to the ABCD<sup>2</sup> Score (ABCD<sup>2</sup>I): a collaborative analysis of unpublished data on 4574 patients. <i>Stroke.</i> 2010; <b>41</b>(9): 1907–13. <a target=xrefwindow id=d28076e3036 href="http://www.ncbi.nlm.nih.gov/pubmed/20634480">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3039 href="http://dx.doi.org/10.1161/STROKEAHA.110.578971">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1092081"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e3048 class=n-a></a>Johnston SC, Rothwell PM, Nguyen-Huynh MN, <i> et al.</i>: Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. <i>Lancet.</i> 2007; <b>369</b>(9558): 283–92. <a target=xrefwindow id=d28076e3059 href="http://www.ncbi.nlm.nih.gov/pubmed/17258668">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3062 href="http://dx.doi.org/10.1016/S0140-6736(07)60150-0">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1092081">F1000 Recommendation</a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/6921960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e3075 class=n-a></a>Merwick A, Albers GW, Amarenco P, <i> et al.</i>: Addition of brain and carotid imaging to the ABCD<sup>2</sup> score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. <i>Lancet Neurol.</i> 2010; <b>9</b>(11): 1060–9. <a target=xrefwindow id=d28076e3089 href="http://www.ncbi.nlm.nih.gov/pubmed/20934388">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3093 href="http://dx.doi.org/10.1016/S1474-4422(10)70240-4">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/6921960">F1000 Recommendation</a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d28076e3106 class=n-a></a>Purroy F, Jiménez Caballero PE, Gorospe A, <i> et al.</i>: Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. <i>Cerebrovasc Dis.</i> 2012; <b>33</b>(2): 182–9. <a target=xrefwindow id=d28076e3117 href="http://www.ncbi.nlm.nih.gov/pubmed/22237056">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3120 href="http://dx.doi.org/10.1159/000334771">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d28076e3130 class=n-a></a>Rothwell PM, Giles MF, Flossmann E, <i> et al.</i>: A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. <i>Lancet.</i> 2005; <b>366</b>(9479): 29–36. <a target=xrefwindow id=d28076e3141 href="http://www.ncbi.nlm.nih.gov/pubmed/15993230">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3144 href="http://dx.doi.org/10.1016/S0140-6736(05)66702-5">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d28076e3153 class=n-a></a>Tsivgoulis G, Spengos K, Manta P, <i> et al.</i>: Validation of the ABCD score in identifying individuals at high early risk of stroke after a transient ischemic attack: a hospital-based case series study. <i>Stroke.</i> 2006; <b>37</b>(12): 2892–7. <a target=xrefwindow id=d28076e3164 href="http://www.ncbi.nlm.nih.gov/pubmed/17053179">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3167 href="http://dx.doi.org/10.1161/01.STR.0000249007.12256.4a">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d28076e3176 class=n-a></a>Redgrave JN, Coutts SB, Schulz UG, <i> et al.</i>: Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack. <i>Stroke.</i> 2007; <b>38</b>(5): 1482–8. <a target=xrefwindow id=d28076e3187 href="http://www.ncbi.nlm.nih.gov/pubmed/17379821">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3190 href="http://dx.doi.org/10.1161/STROKEAHA.106.477380">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d28076e3199 class=n-a></a>Redgrave JN, Schulz UG, Briley D, <i> et al.</i>: Presence of acute ischaemic lesions on diffusion-weighted imaging is associated with clinical predictors of early risk of stroke after transient ischaemic attack. <i>Cerebrovasc Dis.</i> 2007; <b>24</b>(1): 86–90. <a target=xrefwindow id=d28076e3210 href="http://www.ncbi.nlm.nih.gov/pubmed/17519549">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3213 href="http://dx.doi.org/10.1159/000103121">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d28076e3222 class=n-a></a>Lovett JK, Coull AJ, Rothwell PM: Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. <i>Neurology.</i> 2004; <b>62</b>(4): 569–73. <a target=xrefwindow id=d28076e3230 href="http://www.ncbi.nlm.nih.gov/pubmed/14981172">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3233 href="http://dx.doi.org/10.1212/01.WNL.0000110311.09970.83">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d28076e3242 class=n-a></a>Calvet D, Touzé E, Oppenheim C, <i> et al.</i>: DWI lesions and TIA etiology improve the prediction of stroke after TIA. <i>Stroke.</i> 2009; <b>40</b>(1): 187–92. <a target=xrefwindow id=d28076e3253 href="http://www.ncbi.nlm.nih.gov/pubmed/18988917">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3256 href="http://dx.doi.org/10.1161/STROKEAHA.108.515817">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d28076e3266 class=n-a></a>Lodha N, Harrell J, Eisenschenk S, <i> et al.</i>: Motor Impairments in Transient Ischemic Attack Increase the Odds of a Subsequent Stroke: A Meta-Analysis. <i>Front Neurol.</i> 2017; <b>8</b>: 243. <a target=xrefwindow id=d28076e3277 href="http://www.ncbi.nlm.nih.gov/pubmed/28638365">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3280 href="http://dx.doi.org/10.3389/fneur.2017.00243">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3284 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5461338">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d28076e3293 class=n-a></a>Cutting S, Regan E, Lee VH, <i> et al.</i>: High ABCD2 Scores and In-Hospital Interventions following Transient Ischemic Attack. <i>Cerebrovasc Dis Extra.</i> 2016; <b>6</b>(3): 76–83. <a target=xrefwindow id=d28076e3304 href="http://www.ncbi.nlm.nih.gov/pubmed/27721312">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3307 href="http://dx.doi.org/10.1159/000450692">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5091225">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d28076e3320 class=n-a></a>Zhao M, Wang S, Zhang D, <i> et al.</i>: Comparison of Stroke Prediction Accuracy of ABCD2 and ABCD3-I in Patients with Transient Ischemic Attack: A Meta-Analysis. <i>J Stroke Cerebrovasc Dis.</i> 2017; <b>26</b>(10): 2387–2395. <a target=xrefwindow id=d28076e3331 href="http://www.ncbi.nlm.nih.gov/pubmed/28647418">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3334 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.05.030">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d28076e3343 class=n-a></a>Zhang C, Wang Y, Zhao X, <i> et al.</i>: Prediction of Recurrent Stroke or Transient Ischemic Attack After Noncardiogenic Posterior Circulation Ischemic Stroke. <i>Stroke.</i> 2017; <b>48</b>(7): 1835–41. <a target=xrefwindow id=d28076e3354 href="http://www.ncbi.nlm.nih.gov/pubmed/28626054">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3357 href="http://dx.doi.org/10.1161/STROKEAHA.116.016285">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d28076e3366 class=n-a></a>Sen S, Chung M, Duda V, <i> et al.</i>: Periodontal Disease Associated with Aortic Arch Atheroma in Patients with Stroke or Transient Ischemic Attack. <i>J Stroke Cerebrovasc Dis.</i> 2017; <b>26</b>(10): 2137–2144. <a target=xrefwindow id=d28076e3377 href="http://www.ncbi.nlm.nih.gov/pubmed/28551291">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3380 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2017.04.035">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d28076e3389 class=n-a></a>Lavallée PC, Sissani L, Labreuche J, <i> et al.</i>: Clinical Significance of Isolated Atypical Transient Symptoms in a Cohort With Transient Ischemic Attack. <i>Stroke.</i> 2017; <b>48</b>(6): 1495–500. <a target=xrefwindow id=d28076e3400 href="http://www.ncbi.nlm.nih.gov/pubmed/28487336">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3403 href="http://dx.doi.org/10.1161/STROKEAHA.117.016743">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d28076e3413 class=n-a></a>Tanaka K, Uehara T, Kimura K, <i> et al.</i>: Differences in Clinical Characteristics between Patients with Transient Ischemic Attack Whose Symptoms Do and Do Not Persist on Arrival. <i>J Stroke Cerebrovasc Dis.</i> 2016; <b>25</b>(9): 2237–42. <a target=xrefwindow id=d28076e3424 href="http://www.ncbi.nlm.nih.gov/pubmed/27266623">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3427 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.04.025">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d28076e3436 class=n-a></a>Ottaviani M, Vanni S, Moroni F, <i> et al.</i>: Urgent carotid duplex and head computed tomography versus ABCD2 score for risk stratification of patients with transient ischemic attack. <i>Eur J Emerg Med.</i> 2016; <b>23</b>(1): 19–23. <a target=xrefwindow id=d28076e3447 href="http://www.ncbi.nlm.nih.gov/pubmed/24849610">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3450 href="http://dx.doi.org/10.1097/MEJ.0000000000000165">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d28076e3459 class=n-a></a>Purroy F, Jiménez Caballero PE, Gorospe A, <i> et al.</i>: Recurrent transient ischaemic attack and early risk of stroke: data from the PROMAPA study. <i>J Neurol Neurosurg Psychiatr.</i> 2013; <b>84</b>(6): 596–603. <a target=xrefwindow id=d28076e3470 href="http://www.ncbi.nlm.nih.gov/pubmed/23345284">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3473 href="http://dx.doi.org/10.1136/jnnp-2012-304005">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d28076e3482 class=n-a></a>Kapral MK, Hall R, Fang J, <i> et al.</i>: Predictors of Hospitalization in Patients With Transient Ischemic Attack or Minor Ischemic Stroke. <i>Can J Neurol Sci.</i> 2016; <b>43</b>(4): 523–8. <a target=xrefwindow id=d28076e3493 href="http://www.ncbi.nlm.nih.gov/pubmed/27025846">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3496 href="http://dx.doi.org/10.1017/cjn.2016.12">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d28076e3505 class=n-a></a>Kapral MK, Hall R, Fang J, <i> et al.</i>: Association between hospitalization and care after transient ischemic attack or minor stroke. <i>Neurology.</i> 2016; <b>86</b>(17): 1582–9. <a target=xrefwindow id=d28076e3516 href="http://www.ncbi.nlm.nih.gov/pubmed/27016521">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3519 href="http://dx.doi.org/10.1212/WNL.0000000000002614">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4844241">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d28076e3532 class=n-a></a>Lesenskyj AM, Maxwell CR, Veznedaroglu E, <i> et al.</i>: An Analysis of Transient Ischemic Attack Practices: Does Hospital Admission Improve Patient Outcomes? <i>J Stroke Cerebrovasc Dis.</i> 2016; <b>25</b>(9): 2122–5. <a target=xrefwindow id=d28076e3543 href="http://www.ncbi.nlm.nih.gov/pubmed/27450386">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3546 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.06.002">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d28076e3556 class=n-a></a>Phan TG, Srikanth V, Cadilhac DA, <i> et al.</i>: Better outcomes for hospitalized patients with TIA when in stroke units: An observational study. <i>Neurology.</i> 2016; <b>87</b>(16): 1745–6. <a target=xrefwindow id=d28076e3567 href="http://www.ncbi.nlm.nih.gov/pubmed/27754911">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3570 href="http://dx.doi.org/10.1212/WNL.0000000000003277">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d28076e3579 class=n-a></a>Ramirez L, Kim-Tenser MA, Sanossian N, <i> et al.</i>: Trends in Transient Ischemic Attack Hospitalizations in the United States. <i>J Am Heart Assoc.</i> 2016; <b>5</b>(9): pii: e004026. <a target=xrefwindow id=d28076e3590 href="http://www.ncbi.nlm.nih.gov/pubmed/27664805">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3593 href="http://dx.doi.org/10.1161/JAHA.116.004026">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3597 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5079046">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d28076e3606 class=n-a></a>Tibæk M, Dehlendorff C, Jørgensen HS, <i> et al.</i>: Increasing Incidence of Hospitalization for Stroke and Transient Ischemic Attack in Young Adults: A Registry-Based Study. <i>J Am Heart Assoc.</i> 2016; <b>5</b>(5): pii: e003158. <a target=xrefwindow id=d28076e3617 href="http://www.ncbi.nlm.nih.gov/pubmed/27169547">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3620 href="http://dx.doi.org/10.1161/JAHA.115.003158">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3624 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4889186">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d28076e3633 class=n-a></a>Majidi S, Leon Guerrero CR, Burger KM, <i> et al.</i>: Inpatient versus Outpatient Management of TIA or Minor Stroke: Clinical Outcome. <i>J Vasc Interv Neurol.</i> 2017; <b>9</b>(4): 49–53. <a target=xrefwindow id=d28076e3644 href="http://www.ncbi.nlm.nih.gov/pubmed/28702120">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3647 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5501129">Free Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d28076e3656 class=n-a></a>Buisman LR, Rijnsburger AJ, den Hertog HM, <i> et al.</i>: Clinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke. <i>Appl Health Econ Health Policy.</i> 2016; <b>14</b>(1): 67–75. <a target=xrefwindow id=d28076e3667 href="http://www.ncbi.nlm.nih.gov/pubmed/25917685">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3670 href="http://dx.doi.org/10.1007/s40258-015-0167-4">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3674 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4740566">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d28076e3683 class=n-a></a>Hankey GJ, Warlow CP: Cost-effective investigation of patients with suspected transient ischaemic attacks. <i>J Neurol Neurosurg Psychiatr.</i> 1992; <b>55</b>(3): 171–6. <a target=xrefwindow id=d28076e3691 href="http://www.ncbi.nlm.nih.gov/pubmed/1564473">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3694 href="http://dx.doi.org/10.1136/jnnp.55.3.171">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3697 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1014717">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d28076e3707 class=n-a></a>Cadilhac DA, Kim J, Lannin NA, <i> et al.</i>: Better outcomes for hospitalized patients with TIA when in stroke units: An observational study. <i>Neurology.</i> 2016; <b>86</b>(22): 2042–8. <a target=xrefwindow id=d28076e3718 href="http://www.ncbi.nlm.nih.gov/pubmed/27164692">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3721 href="http://dx.doi.org/10.1212/WNL.0000000000002715">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3725 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4891210">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d28076e3734 class=n-a></a>Cruz-Flores S: Acute Stroke and Transient Ischemic Attack in the Outpatient Clinic. <i>Med Clin North Am.</i> 2017; <b>101</b>(3): 479–94. <a target=xrefwindow id=d28076e3742 href="http://www.ncbi.nlm.nih.gov/pubmed/28372708">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3745 href="http://dx.doi.org/10.1016/j.mcna.2017.01.001">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d28076e3754 class=n-a></a>Hosier GW, Phillips SJ, Doucette SP, <i> et al.</i>: Transient ischemic attack: management in the emergency department and impact of an outpatient neurovascular clinic. <i>CJEM.</i> 2016; <b>18</b>(5): 331–9. <a target=xrefwindow id=d28076e3765 href="http://www.ncbi.nlm.nih.gov/pubmed/26879765">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3768 href="http://dx.doi.org/10.1017/cem.2016.3">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d28076e3777 class=n-a></a>Lavallée PC, Meseguer E, Abboud H, <i> et al.</i>: A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. <i>Lancet Neurol.</i> 2007; <b>6</b>(11): 953–60. <a target=xrefwindow id=d28076e3788 href="http://www.ncbi.nlm.nih.gov/pubmed/17928270">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3791 href="http://dx.doi.org/10.1016/S1474-4422(07)70248-X">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1103480"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e3800 class=n-a></a>Rothwell PM, Giles MF, Chandratheva A, <i> et al.</i>: Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. <i>Lancet.</i> 2007; <b>370</b>(9596): 1432–42. <a target=xrefwindow id=d28076e3811 href="http://www.ncbi.nlm.nih.gov/pubmed/17928046">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3814 href="http://dx.doi.org/10.1016/S0140-6736(07)61448-2">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1103480">F1000 Recommendation</a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d28076e3827 class=n-a></a>Agence Nationale d'Accreditation et d'Evaluation en Santé (ANAES): [Early diagnosis and treatment of transient ischemic events in adults--May 2004]. <i>J Mal Vasc.</i> 2005; <b>30</b>: 107–13. <a target=xrefwindow id=d28076e3835 href="http://www.ncbi.nlm.nih.gov/pubmed/16107095">PubMed Abstract </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d28076e3845 class=n-a></a>National Collaborating Centre for Chronic Conditions (UK): Stroke: National Clinical Guideline for Diagnosis and Initial Management of Acute Stroke and Transient Ischaemic Attack (TIA). London: Royal College of Physicians, 2008. <a target=xrefwindow id=d28076e3847 href="http://www.ncbi.nlm.nih.gov/pubmed/21698846">PubMed Abstract </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d28076e3856 class=n-a></a>Studies NIoC: Emergency department stroke and transient ischemic attack care bundle: information and implementation package. Melbourne: National Health and Medical Research Council, 2009. <a target=xrefwindow id=d28076e3858 href="https://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp116_complete.pdf">Reference Source</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d28076e3867 class=n-a></a>Castle J, Mlynash M, Lee K, <i> et al.</i>: Agreement regarding diagnosis of transient ischemic attack fairly low among stroke-trained neurologists. <i>Stroke.</i> 2010; <b>41</b>(7): 1367–70. <a target=xrefwindow id=d28076e3878 href="http://www.ncbi.nlm.nih.gov/pubmed/20508192">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3881 href="http://dx.doi.org/10.1161/STROKEAHA.109.577650">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d28076e3890 class=n-a></a>Kraaijeveld CL, van Gijn J, Schouten HJ, <i> et al.</i>: Interobserver agreement for the diagnosis of transient ischemic attacks. <i>Stroke.</i> 1984; <b>15</b>(4): 723–5. <a target=xrefwindow id=d28076e3901 href="http://www.ncbi.nlm.nih.gov/pubmed/6464066">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3904 href="http://dx.doi.org/10.1161/01.STR.15.4.723">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d28076e3913 class=n-a></a>Dong K, Zhang Q, Ding J, <i> et al.</i>: Mild encephalopathy with a reversible splenial lesion mimicking transient ischemic attack: A case report. <i>Medicine (Baltimore).</i> 2016; <b>95</b>(44): e5258. <a target=xrefwindow id=d28076e3924 href="http://www.ncbi.nlm.nih.gov/pubmed/27858890">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3927 href="http://dx.doi.org/10.1097/MD.0000000000005258">Publisher Full Text </a> | <a target=xrefwindow id=d28076e3931 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5591138">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725410994"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e3940 class=n-a></a>Dutta D, Bowen E, Foy C: Four-year follow-up of transient ischemic attacks, strokes, and mimics: a retrospective transient ischemic attack clinic cohort study. <i>Stroke.</i> 2015; <b>46</b>(5): 1227–32. <a target=xrefwindow id=d28076e3948 href="http://www.ncbi.nlm.nih.gov/pubmed/25813193">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3951 href="http://dx.doi.org/10.1161/STROKEAHA.114.008632">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725410994">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d28076e3965 class=n-a></a>Glibert N, De Keyser J: A transient ischemic attack mimic. <i>Acta Neurol Belg.</i> 2017; 1–2<a target=xrefwindow id=d28076e3970 href="http://www.ncbi.nlm.nih.gov/pubmed/28624950">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3973 href="http://dx.doi.org/10.1007/s13760-017-0809-4">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728308506"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e3982 class=n-a></a>Goyal N, Male S, Al Wafai A, <i> et al.</i>: Cost burden of stroke mimics and transient ischemic attack after intravenous tissue plasminogen activator treatment. <i>J Stroke Cerebrovasc Dis.</i> 2015; <b>24</b>(4): 828–33. <a target=xrefwindow id=d28076e3993 href="http://www.ncbi.nlm.nih.gov/pubmed/25735708">PubMed Abstract </a> | <a target=xrefwindow id=d28076e3996 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2014.11.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728308506">F1000 Recommendation</a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d28076e4009 class=n-a></a>Amort M, Fluri F, Schäfer J, <i> et al.</i>: Transient ischemic attack versus transient ischemic attack mimics: frequency, clinical characteristics and outcome. <i>Cerebrovasc Dis.</i> 2011; <b>32</b>(1): 57–64. <a target=xrefwindow id=d28076e4020 href="http://www.ncbi.nlm.nih.gov/pubmed/21613786">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4023 href="http://dx.doi.org/10.1159/000327034">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d28076e4032 class=n-a></a>Hand PJ, Kwan J, Lindley RI, <i> et al.</i>: Distinguishing between stroke and mimic at the bedside: the brain attack study. <i>Stroke.</i> 2006; <b>37</b>(3): 769–75. <a target=xrefwindow id=d28076e4043 href="http://www.ncbi.nlm.nih.gov/pubmed/16484610">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4046 href="http://dx.doi.org/10.1161/01.STR.0000204041.13466.4c">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d28076e4055 class=n-a></a>Libman RB, Wirkowski E, Alvir J, <i> et al.</i>: Conditions that mimic stroke in the emergency department. Implications for acute stroke trials. <i>Arch Neurol.</i> 1995; <b>52</b>(11): 1119–22. <a target=xrefwindow id=d28076e4066 href="http://www.ncbi.nlm.nih.gov/pubmed/7487564">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4069 href="http://dx.doi.org/10.1001/archneur.1995.00540350113023">Publisher Full Text </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d28076e4078 class=n-a></a>Nadarajan V, Perry RJ, Johnson J, <i> et al.</i>: Transient ischaemic attacks: mimics and chameleons. <i>Pract Neurol.</i> 2014; <b>14</b>(1): 23–31. <a target=xrefwindow id=d28076e4089 href="http://www.ncbi.nlm.nih.gov/pubmed/24453269">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4092 href="http://dx.doi.org/10.1136/practneurol-2013-000782">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4096 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3913122">Free Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d28076e4106 class=n-a></a>Orjuela KD, Gomez CR: Stroke syndromes and their anatomic localization. [online]. <a target=xrefwindow id=d28076e4108 href="http://www.medlink.com/article/stroke_syndromes_and_their_anatomic_localization">Reference Source</a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d28076e4117 class=n-a></a>Ranta A, Alderazi YJ: The importance of specialized stroke care for patients with TIA. <i>Neurology.</i> 2016; <b>86</b>(22): 2030–1. <a target=xrefwindow id=d28076e4125 href="http://www.ncbi.nlm.nih.gov/pubmed/27164700">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4128 href="http://dx.doi.org/10.1212/WNL.0000000000002727">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d28076e4137 class=n-a></a>Sacco RL, Rundek T: The Value of Urgent Specialized Care for TIA and Minor Stroke. <i>N Engl J Med.</i> 2016; <b>374</b>(16): 1577–9. <a target=xrefwindow id=d28076e4145 href="http://www.ncbi.nlm.nih.gov/pubmed/27096584">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4148 href="http://dx.doi.org/10.1056/NEJMe1515730">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a name=d28076e4157 class=n-a></a>Chung J, Park SH, Kim N, <i> et al.</i>: Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification and vascular territory of ischemic stroke lesions diagnosed by diffusion-weighted imaging. <i>J Am Heart Assoc.</i> 2014; <b>3</b>(4): pii: e001119. <a target=xrefwindow id=d28076e4168 href="http://www.ncbi.nlm.nih.gov/pubmed/25112556">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4171 href="http://dx.doi.org/10.1161/JAHA.114.001119">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4175 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4310410">Free Full Text </a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d28076e4184 class=n-a></a>Yaghi S, Rostanski SK, Boehme AK, <i> et al.</i>: Imaging Parameters and Recurrent Cerebrovascular Events in Patients With Minor Stroke or Transient Ischemic Attack. <i>JAMA Neurol.</i> 2016; <b>73</b>(5): 572–8. <a target=xrefwindow id=d28076e4195 href="http://www.ncbi.nlm.nih.gov/pubmed/26998948">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4198 href="http://dx.doi.org/10.1001/jamaneurol.2015.4906">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4202 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5022560">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d28076e4211 class=n-a></a>Adams HP Jr, Bendixen BH, Leira E, <i> et al.</i>: Antithrombotic treatment of ischemic stroke among patients with occlusion or severe stenosis of the internal carotid artery: A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). <i>Neurology.</i> 1999; <b>53</b>(1): 122–5. <a target=xrefwindow id=d28076e4222 href="http://www.ncbi.nlm.nih.gov/pubmed/10408547">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4225 href="http://dx.doi.org/10.1212/WNL.53.1.122">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d28076e4235 class=n-a></a>Wilson CA, Tai W, Desai JA, <i> et al.</i>: Diagnostic Yield of Echocardiography in Transient Ischemic Attack. <i>J Stroke Cerebrovasc Dis.</i> 2016; <b>25</b>(5): 1135–40. <a target=xrefwindow id=d28076e4246 href="http://www.ncbi.nlm.nih.gov/pubmed/26915604">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4249 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.011">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d28076e4258 class=n-a></a>Gomez CR, Labovitz AJ: Transesophageal echocardiography in the etiologic diagnosis of stroke. <i>J Stroke Cerebrovasc Dis.</i> 1991; <b>1</b>(2): 81–7. <a target=xrefwindow id=d28076e4266 href="http://www.ncbi.nlm.nih.gov/pubmed/26487599">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4269 href="http://dx.doi.org/10.1016/S1052-3057(11)80006-6">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d28076e4278 class=n-a></a>Ustrell X, Pellisé A: Cardiac workup of ischemic stroke. <i>Curr Cardiol Rev.</i> 2010; <b>6</b>(3): 175–83. <a target=xrefwindow id=d28076e4286 href="http://www.ncbi.nlm.nih.gov/pubmed/21804776">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4289 href="http://dx.doi.org/10.2174/157340310791658721">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4292 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2994109">Free Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d28076e4301 class=n-a></a>Gomez CR, Tulyapronchote R, Malkoff MD, <i> et al.</i>: Changing trends in the etiologic diagnosis of ischemic stroke. <i>J Stroke Cerebrovasc Dis.</i> 1994; <b>4</b>(3): 169–73. <a target=xrefwindow id=d28076e4312 href="http://www.ncbi.nlm.nih.gov/pubmed/26486055">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4315 href="http://dx.doi.org/10.1016/S1052-3057(10)80181-8">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d28076e4324 class=n-a></a>McGrath ER, Paikin JS, Motlagh B, <i> et al.</i>: Transesophageal echocardiography in patients with cryptogenic ischemic stroke: a systematic review. <i>Am Heart J.</i> 2014; <b>168</b>(5): 706–12. <a target=xrefwindow id=d28076e4335 href="http://www.ncbi.nlm.nih.gov/pubmed/25440799">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4338 href="http://dx.doi.org/10.1016/j.ahj.2014.07.025">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d28076e4347 class=n-a></a>Mercé J, Garcia M, Ustrell X, <i> et al.</i>: Implantable loop recorder: a new tool in the diagnosis of cryptogenic stroke. <i>Rev Esp Cardiol (Engl Ed).</i> 2013; <b>66</b>(8): 665–6. <a target=xrefwindow id=d28076e4358 href="http://www.ncbi.nlm.nih.gov/pubmed/24776339">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4361 href="http://dx.doi.org/10.1016/j.rec.2013.02.001">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d28076e4371 class=n-a></a>Morris JG, Duffis EJ, Fisher M: Cardiac workup of ischemic stroke: can we improve our diagnostic yield? <i>Stroke.</i> 2009; <b>40</b>(8): 2893–8. <a target=xrefwindow id=d28076e4379 href="http://www.ncbi.nlm.nih.gov/pubmed/19478214">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4382 href="http://dx.doi.org/10.1161/STROKEAHA.109.551226">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a name=d28076e4391 class=n-a></a>Pearson AC, Labovitz AJ, Tatineni S, <i> et al.</i>: Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. <i>J Am Coll Cardiol.</i> 1991; <b>17</b>(1): 66–72. <a target=xrefwindow id=d28076e4402 href="http://www.ncbi.nlm.nih.gov/pubmed/1987242">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4405 href="http://dx.doi.org/10.1016/0735-1097(91)90705-E">Publisher Full Text </a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718467600"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4414 class=n-a></a>Sanna T, Diener HC, Passman RS, <i> et al.</i>: Cryptogenic stroke and underlying atrial fibrillation. <i>N Engl J Med.</i> 2014; <b>370</b>(26): 2478–86. <a target=xrefwindow id=d28076e4425 href="http://www.ncbi.nlm.nih.gov/pubmed/24963567">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4428 href="http://dx.doi.org/10.1056/NEJMoa1313600">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718467600">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d28076e4441 class=n-a></a>Bristow MS, Poulin BW, Simon JE, <i> et al.</i>: Identifying lesion growth with MR imaging in acute ischemic stroke. <i>J Magn Reson Imaging.</i> 2008; <b>28</b>(4): 837–46. <a target=xrefwindow id=d28076e4452 href="http://www.ncbi.nlm.nih.gov/pubmed/18821625">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4455 href="http://dx.doi.org/10.1002/jmri.21507">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d28076e4464 class=n-a></a>Förster A, Wenz H, Groden C: Hyperintense Acute Reperfusion Marker on FLAIR in a Patient with Transient Ischemic Attack. <i>Case Rep Radiol.</i> 2016; <b>2016</b>: 9829823. <a target=xrefwindow id=d28076e4472 href="http://www.ncbi.nlm.nih.gov/pubmed/27127673">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4475 href="http://dx.doi.org/10.1155/2016/9829823">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4478 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4834154">Free Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726282884"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4487 class=n-a></a>Grams RW, Kidwell CS, Doshi AH, <i> et al.</i>: Tissue-Negative Transient Ischemic Attack: Is There a Role for Perfusion MRI? <i>AJR Am J Roentgenol.</i> 2016; <b>207</b>(1): 157–62. <a target=xrefwindow id=d28076e4498 href="http://www.ncbi.nlm.nih.gov/pubmed/27070836">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4501 href="http://dx.doi.org/10.2214/AJR.15.15447">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726282884">F1000 Recommendation</a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727611623"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4515 class=n-a></a>Lee J, Inoue M, Mlynash M, <i> et al.</i>: MR perfusion lesions after TIA or minor stroke are associated with new infarction at 7 days. <i>Neurology.</i> 2017; <b>88</b>(24): 2254–9. <a target=xrefwindow id=d28076e4526 href="http://www.ncbi.nlm.nih.gov/pubmed/28500226">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4529 href="http://dx.doi.org/10.1212/WNL.0000000000004039">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727611623">F1000 Recommendation</a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732010900"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4542 class=n-a></a>Lee SH, Nah HW, Kim BJ, <i> et al.</i>: Role of Perfusion-Weighted Imaging in a Diffusion-Weighted-Imaging-Negative Transient Ischemic Attack. <i>J Clin Neurol.</i> 2017; <b>13</b>(2): 129–37. <a target=xrefwindow id=d28076e4553 href="http://www.ncbi.nlm.nih.gov/pubmed/28176500">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4556 href="http://dx.doi.org/10.3988/jcn.2017.13.2.129">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4560 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5392454">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732010900">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d28076e4573 class=n-a></a>Shono K, Satomi J, Tada Y, <i> et al.</i>: Optimal Timing of Diffusion-Weighted Imaging to Avoid False-Negative Findings in Patients With Transient Ischemic Attack. <i>Stroke.</i> 2017; <b>48</b>(7): 1990–2. <a target=xrefwindow id=d28076e4584 href="http://www.ncbi.nlm.nih.gov/pubmed/28536173">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4587 href="http://dx.doi.org/10.1161/STROKEAHA.117.014576">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d28076e4596 class=n-a></a>Coutts SB, Modi J, Patel SK, <i> et al.</i>: CT/CT angiography and MRI findings predict recurrent stroke after transient ischemic attack and minor stroke: results of the prospective CATCH study. <i>Stroke.</i> 2012; <b>43</b>(4): 1013–7. <a target=xrefwindow id=d28076e4607 href="http://www.ncbi.nlm.nih.gov/pubmed/22302109">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4610 href="http://dx.doi.org/10.1161/STROKEAHA.111.637421">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d28076e4619 class=n-a></a>Gomez CR, Kern MJ: Cerebral catheterization: back to the future. <i>J Stroke Cerebrovasc Dis.</i> 1997; <b>6</b>(5): 308–12. <a target=xrefwindow id=d28076e4627 href="http://www.ncbi.nlm.nih.gov/pubmed/17895026">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4630 href="http://dx.doi.org/10.1016/S1052-3057(97)80211-X">Publisher Full Text </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727373205"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4639 class=n-a></a>Qureshi AI, Saleem MA, Aytaç E, <i> et al.</i>: The Effect of Diagnostic Catheter Angiography on Outcomes of Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment. <i>J Vasc Interv Neurol.</i> 2017; <b>9</b>(3): 45–50. <a target=xrefwindow id=d28076e4650 href="http://www.ncbi.nlm.nih.gov/pubmed/28243351">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4653 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5317292">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727373205">F1000 Recommendation</a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725426956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4667 class=n-a></a>Favilla CG, Ingala E, Jara J, <i> et al.</i>: Predictors of finding occult atrial fibrillation after cryptogenic stroke. <i>Stroke.</i> 2015; <b>46</b>(5): 1210–5. <a target=xrefwindow id=d28076e4678 href="http://www.ncbi.nlm.nih.gov/pubmed/25851771">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4681 href="http://dx.doi.org/10.1161/STROKEAHA.114.007763">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725426956">F1000 Recommendation</a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d28076e4694 class=n-a></a>Keach JW, Bradley SM, Turakhia MP, <i> et al.</i>: Early detection of occult atrial fibrillation and stroke prevention. <i>Heart.</i> 2015; <b>101</b>(14): 1097–102. <a target=xrefwindow id=d28076e4705 href="http://www.ncbi.nlm.nih.gov/pubmed/25935765">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4708 href="http://dx.doi.org/10.1136/heartjnl-2015-307588">Publisher Full Text </a></span></li><li><a name=ref-98 class=n-a></a><span class=label>98. </span>&nbsp;<span class=citation><a name=d28076e4717 class=n-a></a>Miller DJ: Prolonged cardiac monitoring after cryptogenic stroke superior to 24 h ECG in detection of occult paroxysmal atrial fibrillation. <i>Evid Based Med.</i> 2014; <b>19</b>(6): 235. <a target=xrefwindow id=d28076e4725 href="http://www.ncbi.nlm.nih.gov/pubmed/25185267">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4728 href="http://dx.doi.org/10.1136/ebmed-2014-110074">Publisher Full Text </a></span></li><li><a name=ref-99 class=n-a></a><span class=label>99. </span>&nbsp;<span class=citation><a name=d28076e4737 class=n-a></a>Miller DJ, Shah K, Modi S, <i> et al.</i>: The Evolution and Application of Cardiac Monitoring for Occult Atrial Fibrillation in Cryptogenic Stroke and TIA. <i>Curr Treat Options Neurol.</i> 2016; <b>18</b>(4): 17. <a target=xrefwindow id=d28076e4748 href="http://www.ncbi.nlm.nih.gov/pubmed/26923607">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4751 href="http://dx.doi.org/10.1007/s11940-016-0400-y">Publisher Full Text </a></span></li><li><a name=ref-100 class=n-a></a><span class=label>100. </span>&nbsp;<span class=citation><a name=d28076e4760 class=n-a></a>Ritter MA, Kochhäuser S, Duning T, <i> et al.</i>: Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. <i>Stroke.</i> 2013; <b>44</b>(5): 1449–52. <a target=xrefwindow id=d28076e4771 href="http://www.ncbi.nlm.nih.gov/pubmed/23449264">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4774 href="http://dx.doi.org/10.1161/STROKEAHA.111.676189">Publisher Full Text </a></span></li><li><a name=ref-101 class=n-a></a><span class=label>101. </span>&nbsp;<span class=citation><a name=d28076e4783 class=n-a></a>Seet RC, Friedman PA, Rabinstein AA: Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. <i>Circulation.</i> 2011; <b>124</b>(4): 477–86. <a target=xrefwindow id=d28076e4791 href="http://www.ncbi.nlm.nih.gov/pubmed/21788600">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4794 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.111.029801">Publisher Full Text </a></span></li><li><a name=ref-102 class=n-a></a><span class=label>102. </span>&nbsp;<span class=citation><a name=d28076e4804 class=n-a></a>Coull AJ, Lovett JK, Rothwell PM, <i> et al.</i>: Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services. <i>BMJ.</i> 2004; <b>328</b>(7435): 326. <a target=xrefwindow id=d28076e4815 href="http://www.ncbi.nlm.nih.gov/pubmed/14744823">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4818 href="http://dx.doi.org/10.1136/bmj.37991.635266.44">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4822 href="http://www.ncbi.nlm.nih.gov/pmc/articles/338101">Free Full Text </a></span></li><li><a name=ref-103 class=n-a></a><span class=label>103. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726374495"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4831 class=n-a></a>Rothwell PM, Algra A, Chen Z, <i> et al.</i>: Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials. <i>Lancet.</i> 2016; <b>388</b>(10042): 365–75. <a target=xrefwindow id=d28076e4842 href="http://www.ncbi.nlm.nih.gov/pubmed/27209146">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4845 href="http://dx.doi.org/10.1016/S0140-6736(16)30468-8">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4849 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5321490">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726374495">F1000 Recommendation</a></span></li><li><a name=ref-104 class=n-a></a><span class=label>104. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726770769"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4862 class=n-a></a>Alberts MJ: Pooled RCTs: After ischemic stroke or TIA, aspirin for secondary prevention reduced early recurrence and severity. <i>Ann Intern Med.</i> 2016; <b>165</b>(6): JC27. <a target=xrefwindow id=d28076e4870 href="http://www.ncbi.nlm.nih.gov/pubmed/27653724">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4873 href="http://dx.doi.org/10.7326/ACPJC-2016-165-6-027">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726770769">F1000 Recommendation</a></span></li><li><a name=ref-105 class=n-a></a><span class=label>105. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726653433"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4886 class=n-a></a>Liu Y, Fei Z, Wang W, <i> et al.</i>: Efficacy and safety of short-term dual- versus mono-antiplatelet therapy in patients with ischemic stroke or TIA: a meta-analysis of 10 randomized controlled trials. <i>J Neurol.</i> 2016; <b>263</b>(11): 2247–59. <a target=xrefwindow id=d28076e4897 href="http://www.ncbi.nlm.nih.gov/pubmed/27541045">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4900 href="http://dx.doi.org/10.1007/s00415-016-8260-7">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726653433">F1000 Recommendation</a></span></li><li><a name=ref-106 class=n-a></a><span class=label>106. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726137287"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4913 class=n-a></a>Wang W, Zhang L, Liu W, <i> et al.</i>: Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis. <i>J Stroke Cerebrovasc Dis.</i> 2016; <b>25</b>(5): 1081–9. <a target=xrefwindow id=d28076e4924 href="http://www.ncbi.nlm.nih.gov/pubmed/26856461">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4927 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.01.026">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726137287">F1000 Recommendation</a></span></li><li><a name=ref-107 class=n-a></a><span class=label>107. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727778584"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4940 class=n-a></a>Zhou X, Tian J, Zhu MZ, <i> et al.</i>: A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke. <i>Exp Ther Med.</i> 2017; <b>14</b>(1): 324–32. <a target=xrefwindow id=d28076e4951 href="http://www.ncbi.nlm.nih.gov/pubmed/28672933">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4954 href="http://dx.doi.org/10.3892/etm.2017.4459">Publisher Full Text </a> | <a target=xrefwindow id=d28076e4958 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5488532">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727778584">F1000 Recommendation</a></span></li><li><a name=ref-108 class=n-a></a><span class=label>108. </span>&nbsp;<span class=citation><a name=d28076e4972 class=n-a></a>Jauch EC, Saver JL, Adams HP Jr, <i> et al.</i>: Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke.</i> 2013; <b>44</b>(3): 870–947. <a target=xrefwindow id=d28076e4983 href="http://www.ncbi.nlm.nih.gov/pubmed/23370205">PubMed Abstract </a> | <a target=xrefwindow id=d28076e4986 href="http://dx.doi.org/10.1161/STR.0b013e318284056a">Publisher Full Text </a></span></li><li><a name=ref-109 class=n-a></a><span class=label>109. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727830149"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e4995 class=n-a></a>Bahouth MN, Bahrainwala Z, Hillis AE, <i> et al.</i>: Dehydration Status is Associated With More Severe Hemispatial Neglect After Stroke. <i>Neurologist.</i> 2016; <b>21</b>(6): 101–5. <a target=xrefwindow id=d28076e5006 href="http://www.ncbi.nlm.nih.gov/pubmed/27801770">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5009 href="http://dx.doi.org/10.1097/NRL.0000000000000101">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5013 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5282514">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727830149">F1000 Recommendation</a></span></li><li><a name=ref-110 class=n-a></a><span class=label>110. </span>&nbsp;<span class=citation><a name=d28076e5026 class=n-a></a>Kelly J, Hunt BJ, Lewis RR, <i> et al.</i>: Dehydration and venous thromboembolism after acute stroke. <i>QJM.</i> 2004; <b>97</b>(5): 293–6. <a target=xrefwindow id=d28076e5037 href="http://www.ncbi.nlm.nih.gov/pubmed/15100423">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5040 href="http://dx.doi.org/10.1093/qjmed/hch050">Publisher Full Text </a></span></li><li><a name=ref-111 class=n-a></a><span class=label>111. </span>&nbsp;<span class=citation><a name=d28076e5049 class=n-a></a>Liu CH, Lin SC, Lin JR, <i> et al.</i>: Dehydration is an independent predictor of discharge outcome and admission cost in acute ischaemic stroke. <i>Eur J Neurol.</i> 2014; <b>21</b>(9): 1184–91. <a target=xrefwindow id=d28076e5060 href="http://www.ncbi.nlm.nih.gov/pubmed/24780071">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5063 href="http://dx.doi.org/10.1111/ene.12452">Publisher Full Text </a></span></li><li><a name=ref-112 class=n-a></a><span class=label>112. </span>&nbsp;<span class=citation><a name=d28076e5072 class=n-a></a>Rowat A, Graham C, Dennis M: Dehydration in hospital-admitted stroke patients: detection, frequency, and association. <i>Stroke.</i> 2012; <b>43</b>(3): 857–9. <a target=xrefwindow id=d28076e5080 href="http://www.ncbi.nlm.nih.gov/pubmed/22156691">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5083 href="http://dx.doi.org/10.1161/STROKEAHA.111.640821">Publisher Full Text </a></span></li><li><a name=ref-113 class=n-a></a><span class=label>113. </span>&nbsp;<span class=citation><a name=d28076e5092 class=n-a></a>Rowat A, Smith L, Graham C, <i> et al.</i>: A pilot study to assess if urine specific gravity and urine colour charts are useful indicators of dehydration in acute stroke patients. <i>J Adv Nurs.</i> 2011; <b>67</b>(9): 1976–83. <a target=xrefwindow id=d28076e5103 href="http://www.ncbi.nlm.nih.gov/pubmed/21507048">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5106 href="http://dx.doi.org/10.1111/j.1365-2648.2011.05645.x">Publisher Full Text </a></span></li><li><a name=ref-114 class=n-a></a><span class=label>114. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726376304"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5116 class=n-a></a>Swerdel JN, Janevic TM, Kostis WJ, <i> et al.</i>: Association Between Dehydration and Short-Term Risk of Ischemic Stroke in Patients with Atrial Fibrillation. <i>Transl Stroke Res.</i> 2017; <b>8</b>(2): 122–30. <a target=xrefwindow id=d28076e5127 href="http://www.ncbi.nlm.nih.gov/pubmed/27212039">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5130 href="http://dx.doi.org/10.1007/s12975-016-0471-9">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726376304">F1000 Recommendation</a></span></li><li><a name=ref-115 class=n-a></a><span class=label>115. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727717944"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5143 class=n-a></a>Wu FF, Hung YC, Tsai YH, <i> et al.</i>: The influence of dehydration on the prognosis of acute ischemic stroke for patients treated with tissue plasminogen activator. <i>BMC Cardiovasc Disord.</i> 2017; <b>17</b>(1): 154. <a target=xrefwindow id=d28076e5154 href="http://www.ncbi.nlm.nih.gov/pubmed/28610565">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5157 href="http://dx.doi.org/10.1186/s12872-017-0590-6">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5161 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5470225">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727717944">F1000 Recommendation</a></span></li><li><a name=ref-116 class=n-a></a><span class=label>116. </span>&nbsp;<span class=citation><a name=d28076e5174 class=n-a></a>Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. <i>BMJ.</i> 2002; <b>324</b>(7329): 71–86. <a target=xrefwindow id=d28076e5182 href="http://www.ncbi.nlm.nih.gov/pubmed/11786451">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5185 href="http://dx.doi.org/10.1136/bmj.324.7329.71">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5188 href="http://www.ncbi.nlm.nih.gov/pmc/articles/64503">Free Full Text </a></span></li><li><a name=ref-117 class=n-a></a><span class=label>117. </span>&nbsp;<span class=citation><a name=d28076e5197 class=n-a></a>McQuaid KR, Laine L: Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. <i>Am J Med.</i> 2006; <b>119</b>(8): 624–38. <a target=xrefwindow id=d28076e5205 href="http://www.ncbi.nlm.nih.gov/pubmed/16887404">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5208 href="http://dx.doi.org/10.1016/j.amjmed.2005.10.039">Publisher Full Text </a></span></li><li><a name=ref-118 class=n-a></a><span class=label>118. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1107032"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5217 class=n-a></a>Kennedy J, Hill MD, Ryckborst KJ, <i> et al.</i>: Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. <i>Lancet Neurol.</i> 2007; <b>6</b>(11): 961–9. <a target=xrefwindow id=d28076e5228 href="http://www.ncbi.nlm.nih.gov/pubmed/17931979">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5231 href="http://dx.doi.org/10.1016/S1474-4422(07)70250-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1107032">F1000 Recommendation</a></span></li><li><a name=ref-119 class=n-a></a><span class=label>119. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718023372"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5244 class=n-a></a>Wang Y, Wang Y, Zhao X, <i> et al.</i>: Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. <i>N Engl J Med.</i> 2013; <b>369</b>(1): 11–9. <a target=xrefwindow id=d28076e5255 href="http://www.ncbi.nlm.nih.gov/pubmed/23803136">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5258 href="http://dx.doi.org/10.1056/NEJMoa1215340">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718023372">F1000 Recommendation</a></span></li><li><a name=ref-120 class=n-a></a><span class=label>120. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725481157"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5272 class=n-a></a>Wang Y, Pan Y, Zhao X, <i> et al.</i>: Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes. <i>Circulation.</i> 2015; <b>132</b>(1): 40–6. <a target=xrefwindow id=d28076e5283 href="http://www.ncbi.nlm.nih.gov/pubmed/25957224">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5286 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.114.014791">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725481157">F1000 Recommendation</a></span></li><li><a name=ref-121 class=n-a></a><span class=label>121. </span>&nbsp;<span class=citation><a name=d28076e5299 class=n-a></a>Johnston SC, Easton JD, Farrant M, <i> et al.</i>: Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. <i>Int J Stroke.</i> 2013; <b>8</b>(6): 479–83. <a target=xrefwindow id=d28076e5310 href="http://www.ncbi.nlm.nih.gov/pubmed/23879752">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5313 href="http://dx.doi.org/10.1111/ijs.12129">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5317 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4412261">Free Full Text </a></span></li><li><a name=ref-122 class=n-a></a><span class=label>122. </span>&nbsp;<span class=citation><a name=d28076e5326 class=n-a></a>Diener H, Bogousslavsky JC, Brass LM, <i> et al.</i>: Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. <i>Lancet.</i> 2004; <b>364</b>(9431): 331–7. <a target=xrefwindow id=d28076e5337 href="http://www.ncbi.nlm.nih.gov/pubmed/15276392">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5340 href="http://dx.doi.org/10.1016/S0140-6736(04)16721-4">Publisher Full Text </a></span></li><li><a name=ref-123 class=n-a></a><span class=label>123. </span>&nbsp;<span class=citation><a name=d28076e5349 class=n-a></a>Hankey GJ, Johnston SC, Easton JD, <i> et al.</i>: Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial. <i>Int J Stroke.</i> 2011; <b>6</b>(1): 3–9. <a target=xrefwindow id=d28076e5360 href="http://www.ncbi.nlm.nih.gov/pubmed/21205234">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5363 href="http://dx.doi.org/10.1111/j.1747-4949.2010.00535.x">Publisher Full Text </a></span></li><li><a name=ref-124 class=n-a></a><span class=label>124. </span>&nbsp;<span class=citation><a name=d28076e5372 class=n-a></a>Bath PM, Robson K, Woodhouse LJ, <i> et al.</i>: Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial. <i>Int J Stroke.</i> 2015; <b>10</b>(3): 449–51. <a target=xrefwindow id=d28076e5383 href="http://www.ncbi.nlm.nih.gov/pubmed/25640807">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5386 href="http://dx.doi.org/10.1111/ijs.12445">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5390 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4409839">Free Full Text </a></span></li><li><a name=ref-125 class=n-a></a><span class=label>125. </span>&nbsp;<span class=citation><a name=d28076e5399 class=n-a></a>TARDIS Trial Investigators, Krishnan K, Beridze M, <i> et al.</i>: Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388). <i>Int J Stroke.</i> 2015; <b>10</b>(7): 1159–65. <a target=xrefwindow id=d28076e5410 href="http://www.ncbi.nlm.nih.gov/pubmed/26079743">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5413 href="http://dx.doi.org/10.1111/ijs.12538">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5417 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4855643">Free Full Text </a></span></li><li><a name=ref-126 class=n-a></a><span class=label>126. </span>&nbsp;<span class=citation><a name=d28076e5427 class=n-a></a>Diener HC, Cunha L, Forbes C, <i> et al.</i>: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. <i>J Neurol Sci.</i> 1996; <b>143</b>(1–2): 1–13. <a target=xrefwindow id=d28076e5438 href="http://www.ncbi.nlm.nih.gov/pubmed/8981292">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5441 href="http://dx.doi.org/10.1016/S0022-510X(96)00308-5">Publisher Full Text </a></span></li><li><a name=ref-127 class=n-a></a><span class=label>127. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13961"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5450 class=n-a></a>ESPRIT Study Group, Halkes PH, van Gijn J, <i> et al.</i>: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. <i>Lancet.</i> 2006; <b>367</b>(9523): 1665–73. <a target=xrefwindow id=d28076e5461 href="http://www.ncbi.nlm.nih.gov/pubmed/16714187">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5464 href="http://dx.doi.org/10.1016/S0140-6736(06)68734-5">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13961">F1000 Recommendation</a></span></li><li><a name=ref-128 class=n-a></a><span class=label>128. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1120896"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5477 class=n-a></a>Sacco RL, Diener H, Yusuf S, <i> et al.</i>: Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. <i>N Engl J Med.</i> 2008; <b>359</b>(12): 1238–51. <a target=xrefwindow id=d28076e5488 href="http://www.ncbi.nlm.nih.gov/pubmed/18753638">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5491 href="http://dx.doi.org/10.1056/NEJMoa0805002">Publisher Full Text </a> | <a target=xrefwindow id=d28076e5495 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2714259">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1120896">F1000 Recommendation</a></span></li><li><a name=ref-129 class=n-a></a><span class=label>129. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727349102"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5508 class=n-a></a>Amarenco P, Albers GW, Denison H, <i> et al.</i>: Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. <i>Lancet Neurol.</i> 2017; <b>16</b>(4): 301–10. <a target=xrefwindow id=d28076e5519 href="http://www.ncbi.nlm.nih.gov/pubmed/28238711">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5522 href="http://dx.doi.org/10.1016/S1474-4422(17)30038-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727349102">F1000 Recommendation</a></span></li><li><a name=ref-130 class=n-a></a><span class=label>130. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727756463"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5535 class=n-a></a>Easton JD, Aunes M, Albers GW, <i> et al.</i>: Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). <i>Circulation.</i> 2017; <b>136</b>(10): 907–16. <a target=xrefwindow id=d28076e5546 href="http://www.ncbi.nlm.nih.gov/pubmed/28655834">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5549 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028566">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727756463">F1000 Recommendation</a></span></li><li><a name=ref-131 class=n-a></a><span class=label>131. </span>&nbsp;<span class=citation><a name=d28076e5562 class=n-a></a>Johnston SC, Amarenco P, Albers GW, <i> et al.</i>: Acute Stroke or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes (SOCRATES) trial: rationale and design. <i>Int J Stroke.</i> 2015; <b>10</b>(8): 1304–8. <a target=xrefwindow id=d28076e5573 href="http://www.ncbi.nlm.nih.gov/pubmed/26311628">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5576 href="http://dx.doi.org/10.1111/ijs.12610">Publisher Full Text </a></span></li><li><a name=ref-132 class=n-a></a><span class=label>132. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727054402"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5586 class=n-a></a>Wang Y, Minematsu K, Wong KS, <i> et al.</i>: Ticagrelor in Acute Stroke or Transient Ischemic Attack in Asian Patients: From the SOCRATES Trial (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes). <i>Stroke.</i> 2017; <b>48</b>(1): 167–73. <a target=xrefwindow id=d28076e5597 href="http://www.ncbi.nlm.nih.gov/pubmed/27899747">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5600 href="http://dx.doi.org/10.1161/STROKEAHA.116.014891">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727054402">F1000 Recommendation</a></span></li><li><a name=ref-133 class=n-a></a><span class=label>133. </span>&nbsp;<span class=citation><a name=d28076e5613 class=n-a></a>Kamal AK, Naqvi I, Husain MR, <i> et al.</i>: Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. <i>Cochrane Database Syst Rev.</i> 2011; (1): CD008076. <a target=xrefwindow id=d28076e5621 href="http://www.ncbi.nlm.nih.gov/pubmed/21249700">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5624 href="http://dx.doi.org/10.1002/14651858.CD008076.pub2">Publisher Full Text </a></span></li><li><a name=ref-134 class=n-a></a><span class=label>134. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718304413"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e5633 class=n-a></a>Hart RG, Pearce LA, Aguilar MI: Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. <i>Ann Intern Med.</i> 2007; <b>146</b>(12): 857–67. <a target=xrefwindow id=d28076e5641 href="http://www.ncbi.nlm.nih.gov/pubmed/17577005">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5644 href="http://dx.doi.org/10.7326/0003-4819-146-12-200706190-00007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718304413">F1000 Recommendation</a></span></li><li><a name=ref-135 class=n-a></a><span class=label>135. </span>&nbsp;<span class=citation><a name=d28076e5657 class=n-a></a>Zhang E, Liu T, Li Z, <i> et al.</i>: High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography. <i>Int J Cardiol.</i> 2015; <b>184</b>: 540–2. <a target=xrefwindow id=d28076e5668 href="http://www.ncbi.nlm.nih.gov/pubmed/25767011">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5671 href="http://dx.doi.org/10.1016/j.ijcard.2015.02.109">Publisher Full Text </a></span></li><li><a name=ref-136 class=n-a></a><span class=label>136. </span>&nbsp;<span class=citation><a name=d28076e5680 class=n-a></a>Tanasa I, Arhirii R, Popa R, <i> et al.</i>: Echocardiography for assessment of left atrial stasis and thrombosis - three cases report. <i>Arch Clin Cases.</i> 2015; <b>2</b>(2): 86–90. <a target=xrefwindow id=d28076e5691 href="http://dx.doi.org/10.22551/2015.06.0202.10038">Publisher Full Text </a></span></li><li><a name=ref-137 class=n-a></a><span class=label>137. </span>&nbsp;<span class=citation><a name=d28076e5700 class=n-a></a>Kleemann T, Becker T, Strauss M, <i> et al.</i>: Prevalence of left atrial thrombus and dense spontaneous echo contrast in patients with short-term atrial fibrillation &lt; 48 hours undergoing cardioversion: value of transesophageal echocardiography to guide cardioversion. <i>J Am Soc Echocardiogr.</i> 2009; <b>22</b>(12): 1403–8. <a target=xrefwindow id=d28076e5711 href="http://www.ncbi.nlm.nih.gov/pubmed/19880280">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5714 href="http://dx.doi.org/10.1016/j.echo.2009.09.015">Publisher Full Text </a></span></li><li><a name=ref-138 class=n-a></a><span class=label>138. </span>&nbsp;<span class=citation><a name=d28076e5724 class=n-a></a>Bernhardt P, Schmidt H, Hammerstingl C, <i> et al.</i>: Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. <i>J Am Coll Cardiol.</i> 2005; <b>45</b>(11): 1807–12. <a target=xrefwindow id=d28076e5735 href="http://www.ncbi.nlm.nih.gov/pubmed/15936610">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5738 href="http://dx.doi.org/10.1016/j.jacc.2004.11.071">Publisher Full Text </a></span></li><li><a name=ref-139 class=n-a></a><span class=label>139. </span>&nbsp;<span class=citation><a name=d28076e5747 class=n-a></a>Vincelj J, Sokol I, Jaksić O: Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography. <i>Echocardiography.</i> 2002; <b>19</b>(4): 319–24. <a target=xrefwindow id=d28076e5755 href="http://www.ncbi.nlm.nih.gov/pubmed/12047783">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5758 href="http://dx.doi.org/10.1046/j.1540-8175.2002.00319.x">Publisher Full Text </a></span></li><li><a name=ref-140 class=n-a></a><span class=label>140. </span>&nbsp;<span class=citation><a name=d28076e5767 class=n-a></a>Goswami KC, Yadav R, Rao MB, <i> et al.</i>: Clinical and echocardiographic predictors of left atrial clot and spontaneous echo contrast in patients with severe rheumatic mitral stenosis: a prospective study in 200 patients by transesophageal echocardiography. <i>Int J Cardiol.</i> 2000; <b>73</b>(3): 273–9. <a target=xrefwindow id=d28076e5778 href="http://www.ncbi.nlm.nih.gov/pubmed/10841970">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5781 href="http://dx.doi.org/10.1016/S0167-5273(00)00235-7">Publisher Full Text </a></span></li><li><a name=ref-141 class=n-a></a><span class=label>141. </span>&nbsp;<span class=citation><a name=d28076e5790 class=n-a></a>Peverill RE, Gelman J, Harper RW, <i> et al.</i>: Stability of left atrial spontaneous echo contrast at repeat transesophageal echocardiography in patients with mitral stenosis. <i>Am J Cardiol.</i> 1997; <b>79</b>(4): 516–8. <a target=xrefwindow id=d28076e5801 href="http://www.ncbi.nlm.nih.gov/pubmed/9052365">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5804 href="http://dx.doi.org/10.1016/S0002-9149(96)00800-4">Publisher Full Text </a></span></li><li><a name=ref-142 class=n-a></a><span class=label>142. </span>&nbsp;<span class=citation><a name=d28076e5813 class=n-a></a>Irani WN, Grayburn PA, Afridi I: Prevalence of thrombus, spontaneous echo contrast, and atrial stunning in patients undergoing cardioversion of atrial flutter. A prospective study using transesophageal echocardiography. <i>Circulation.</i> 1997; <b>95</b>(4): 962–6. <a target=xrefwindow id=d28076e5821 href="http://www.ncbi.nlm.nih.gov/pubmed/9054758">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5824 href="http://dx.doi.org/10.1161/01.CIR.95.4.962">Publisher Full Text </a></span></li><li><a name=ref-143 class=n-a></a><span class=label>143. </span>&nbsp;<span class=citation><a name=d28076e5833 class=n-a></a>Kamenský G, Drahos P, Plevová N: Left atrial spontaneous echo contrast: its prevalence and importance in patients undergoing transesophageal echocardiography and particularly those with a cerebrovascular embolic event. <i>J Am Soc Echocardiogr.</i> 1996; <b>9</b>(1): 62–70. <a target=xrefwindow id=d28076e5841 href="http://www.ncbi.nlm.nih.gov/pubmed/8679238">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5844 href="http://dx.doi.org/10.1016/S0894-7317(96)90105-4">Publisher Full Text </a></span></li><li><a name=ref-144 class=n-a></a><span class=label>144. </span>&nbsp;<span class=citation><a name=d28076e5854 class=n-a></a>von der Recke G, Schmidt H, Illien S, <i> et al.</i>: Transesophageal contrast echocardiography distinguishes a left atrial appendage thrombus from spontaneous echo contrast. <i>Echocardiography.</i> 2002; <b>19</b>(4): 343–4. <a target=xrefwindow id=d28076e5865 href="http://www.ncbi.nlm.nih.gov/pubmed/12047789">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5868 href="http://dx.doi.org/10.1046/j.1540-8175.2002.00343.x">Publisher Full Text </a></span></li><li><a name=ref-145 class=n-a></a><span class=label>145. </span>&nbsp;<span class=citation><a name=d28076e5877 class=n-a></a>Bashir M, Asher CR, Schaffer K, <i> et al.</i>: Left atrial appendage spontaneous echo contrast in patients with atrial arrhythmias using integrated backscatter and transesophageal echocardiography. <i>Am J Cardiol.</i> 2001; <b>88</b>(8): 923–7, A9. <a target=xrefwindow id=d28076e5888 href="http://www.ncbi.nlm.nih.gov/pubmed/11676967">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5891 href="http://dx.doi.org/10.1016/S0002-9149(01)01911-7">Publisher Full Text </a></span></li><li><a name=ref-146 class=n-a></a><span class=label>146. </span>&nbsp;<span class=citation><a name=d28076e5900 class=n-a></a>Kato H, Nakanishi M, Maekawa N, <i> et al.</i>: Evaluation of left atrial appendage stasis in patients with atrial fibrillation using transesophageal echocardiography with an intravenous albumin-contrast agent. <i>Am J Cardiol.</i> 1996; <b>78</b>(3): 365–9. <a target=xrefwindow id=d28076e5911 href="http://www.ncbi.nlm.nih.gov/pubmed/8759824">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5914 href="http://dx.doi.org/10.1016/S0002-9149(96)00297-4">Publisher Full Text </a></span></li><li><a name=ref-147 class=n-a></a><span class=label>147. </span>&nbsp;<span class=citation><a name=d28076e5923 class=n-a></a>Fatkin D, Feneley M: Stratification of thromboembolic risk of atrial fibrillation by transthoracic echocardiography and transesophageal echocardiography: the relative role of left atrial appendage function, mitral valve disease, and spontaneous echocardiographic contrast. <i>Prog Cardiovasc Dis.</i> 1996; <b>39</b>(1): 57–68. <a target=xrefwindow id=d28076e5931 href="http://www.ncbi.nlm.nih.gov/pubmed/8693096">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5934 href="http://dx.doi.org/10.1016/S0033-0620(96)80041-7">Publisher Full Text </a></span></li><li><a name=ref-148 class=n-a></a><span class=label>148. </span>&nbsp;<span class=citation><a name=d28076e5943 class=n-a></a>Appelros P: Heart failure and stroke. <i>Stroke.</i> 2006; <b>37</b>(7): 1637. <a target=xrefwindow id=d28076e5951 href="http://www.ncbi.nlm.nih.gov/pubmed/16741171">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5954 href="http://dx.doi.org/10.1161/01.STR.0000227197.16951.2b">Publisher Full Text </a></span></li><li><a name=ref-149 class=n-a></a><span class=label>149. </span>&nbsp;<span class=citation><a name=d28076e5963 class=n-a></a>Devulapalli S, Dunlap S, Wilson N, <i> et al.</i>: Prevalence and clinical correlation of left ventricular systolic dysfunction in african americans with ischemic stroke. <i>J Stroke Cerebrovasc Dis.</i> 2014; <b>23</b>(7): 1965–8. <a target=xrefwindow id=d28076e5974 href="http://www.ncbi.nlm.nih.gov/pubmed/24784011">PubMed Abstract </a> | <a target=xrefwindow id=d28076e5977 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2014.01.026">Publisher Full Text </a></span></li><li><a name=ref-150 class=n-a></a><span class=label>150. </span>&nbsp;<span class=citation><a name=d28076e5987 class=n-a></a>Hays AG, Sacco RL, Rundek T, <i> et al.</i>: Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population. <i>Stroke.</i> 2006; <b>37</b>(7): 1715–9. <a target=xrefwindow id=d28076e5998 href="http://www.ncbi.nlm.nih.gov/pubmed/16741172">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6001 href="http://dx.doi.org/10.1161/01.STR.0000227121.34717.40">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6005 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2677017">Free Full Text </a></span></li><li><a name=ref-151 class=n-a></a><span class=label>151. </span>&nbsp;<span class=citation><a name=d28076e6014 class=n-a></a>McMurray JJ, Ezekowitz JA, Lewis BS, <i> et al.</i>: Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. <i>Circ Heart Fail.</i> 2013; <b>6</b>(3): 451–60. <a target=xrefwindow id=d28076e6025 href="http://www.ncbi.nlm.nih.gov/pubmed/23575255">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6028 href="http://dx.doi.org/10.1161/CIRCHEARTFAILURE.112.000143">Publisher Full Text </a></span></li><li><a name=ref-152 class=n-a></a><span class=label>152. </span>&nbsp;<span class=citation><a name=d28076e6037 class=n-a></a>Witt BJ, Brown RD Jr, Jacobsen SJ, <i> et al.</i>: Ischemic stroke after heart failure: a community-based study. <i>Am Heart J.</i> 2006; <b>152</b>(1): 102–9. <a target=xrefwindow id=d28076e6048 href="http://www.ncbi.nlm.nih.gov/pubmed/16824838">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6051 href="http://dx.doi.org/10.1016/j.ahj.2005.10.018">Publisher Full Text </a></span></li><li><a name=ref-153 class=n-a></a><span class=label>153. </span>&nbsp;<span class=citation><a name=d28076e6060 class=n-a></a>Witt BJ, Gami AS, Ballman KV, <i> et al.</i>: The incidence of ischemic stroke in chronic heart failure: a meta-analysis. <i>J Card Fail.</i> 2007; <b>13</b>(6): 489–96. <a target=xrefwindow id=d28076e6071 href="http://www.ncbi.nlm.nih.gov/pubmed/17675064">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6074 href="http://dx.doi.org/10.1016/j.cardfail.2007.01.009">Publisher Full Text </a></span></li><li><a name=ref-154 class=n-a></a><span class=label>154. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1474959"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6083 class=n-a></a>Connolly SJ, Ezekowitz MD, Yusuf S, <i> et al.</i>: Dabigatran versus warfarin in patients with atrial fibrillation. <i>N Engl J Med.</i> 2009; <b>361</b>(12): 1139–51. <a target=xrefwindow id=d28076e6094 href="http://www.ncbi.nlm.nih.gov/pubmed/19717844">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6097 href="http://dx.doi.org/10.1056/NEJMoa0905561">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1474959">F1000 Recommendation</a></span></li><li><a name=ref-155 class=n-a></a><span class=label>155. </span>&nbsp;<span class=citation><a name=d28076e6110 class=n-a></a>Connolly SJ, Wallentin L, Ezekowitz MD, <i> et al.</i>: The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study. <i>Circulation.</i> 2013; <b>128</b>(3): 237–43. <a target=xrefwindow id=d28076e6121 href="http://www.ncbi.nlm.nih.gov/pubmed/23770747">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6124 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.001139">Publisher Full Text </a></span></li><li><a name=ref-156 class=n-a></a><span class=label>156. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717969694"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6134 class=n-a></a>Dans AL, Connolly SJ, Wallentin L, <i> et al.</i>: Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. <i>Circulation.</i> 2013; <b>127</b>(5): 634–40. <a target=xrefwindow id=d28076e6145 href="http://www.ncbi.nlm.nih.gov/pubmed/23271794">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6148 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.115386">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717969694">F1000 Recommendation</a></span></li><li><a name=ref-157 class=n-a></a><span class=label>157. </span>&nbsp;<span class=citation><a name=d28076e6161 class=n-a></a>Diener HC, Connolly SJ, Ezekowitz MD, <i> et al.</i>: Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial. <i>Lancet Neurol.</i> 2010; <b>9</b>(12): 1157–63. <a target=xrefwindow id=d28076e6172 href="http://www.ncbi.nlm.nih.gov/pubmed/21059484">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6175 href="http://dx.doi.org/10.1016/S1474-4422(10)70274-X">Publisher Full Text </a></span></li><li><a name=ref-158 class=n-a></a><span class=label>158. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727624848"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6184 class=n-a></a>Verdecchia P, Reboldi G, Angeli F, <i> et al.</i>: Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation- the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study. <i>Europace.</i> 2017. <a target=xrefwindow id=d28076e6192 href="http://www.ncbi.nlm.nih.gov/pubmed/28520924">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6195 href="http://dx.doi.org/10.1093/europace/eux022">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727624848">F1000 Recommendation</a></span></li><li><a name=ref-159 class=n-a></a><span class=label>159. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/9310957"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6208 class=n-a></a>Connolly SJ, Eikelboom J, Joyner C, <i> et al.</i>: Apixaban in patients with atrial fibrillation. <i>N Engl J Med.</i> 2011; <b>364</b>(9): 806–17. <a target=xrefwindow id=d28076e6219 href="http://www.ncbi.nlm.nih.gov/pubmed/21309657">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6222 href="http://dx.doi.org/10.1056/NEJMoa1007432">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/9310957">F1000 Recommendation</a></span></li><li><a name=ref-160 class=n-a></a><span class=label>160. </span>&nbsp;<span class=citation><a name=d28076e6235 class=n-a></a>Eikelboom JW, Connolly SJ, Gao P, <i> et al.</i>: Stroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney disease. <i>J Stroke Cerebrovasc Dis.</i> 2012; <b>21</b>(6): 429–35. <a target=xrefwindow id=d28076e6246 href="http://www.ncbi.nlm.nih.gov/pubmed/22818021">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6249 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2012.05.007">Publisher Full Text </a></span></li><li><a name=ref-161 class=n-a></a><span class=label>161. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13199976"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6258 class=n-a></a>Granger CB, Alexander JH, McMurray JJ, <i> et al.</i>: Apixaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med.</i> 2011; <b>365</b>(11): 981–92. <a target=xrefwindow id=d28076e6269 href="http://www.ncbi.nlm.nih.gov/pubmed/21870978">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6272 href="http://dx.doi.org/10.1056/NEJMoa1107039">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13199976">F1000 Recommendation</a></span></li><li><a name=ref-162 class=n-a></a><span class=label>162. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725953599"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6286 class=n-a></a>Ng KH, Shestakovska O, Connolly SJ, <i> et al.</i>: Efficacy and safety of apixaban compared with aspirin in the elderly: a subgroup analysis from the AVERROES trial. <i>Age Ageing.</i> 2016; <b>45</b>(1): 77–83. <a target=xrefwindow id=d28076e6297 href="http://www.ncbi.nlm.nih.gov/pubmed/26590293">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6300 href="http://dx.doi.org/10.1093/ageing/afv156">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725953599">F1000 Recommendation</a></span></li><li><a name=ref-163 class=n-a></a><span class=label>163. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726624430"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6313 class=n-a></a>O'Donnell MJ, Eikelboom JW, Yusuf S, <i> et al.</i>: Effect of apixaban on brain infarction and microbleeds: AVERROES-MRI assessment study. <i>Am Heart J.</i> 2016; <b>178</b>: 145–50. <a target=xrefwindow id=d28076e6324 href="http://www.ncbi.nlm.nih.gov/pubmed/27502862">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6327 href="http://dx.doi.org/10.1016/j.ahj.2016.03.019">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726624430">F1000 Recommendation</a></span></li><li><a name=ref-164 class=n-a></a><span class=label>164. </span>&nbsp;<span class=citation><a name=d28076e6340 class=n-a></a>Peterson BE, Al-Khatib SM, Granger CB: Apixaban to prevent stroke in patients with atrial fibrillation: a review. <i>Ther Adv Cardiovasc Dis.</i> 2017; <b>11</b>(3): 91–104. <a target=xrefwindow id=d28076e6348 href="http://www.ncbi.nlm.nih.gov/pubmed/27342651">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6351 href="http://dx.doi.org/10.1177/1753944716652787">Publisher Full Text </a></span></li><li><a name=ref-165 class=n-a></a><span class=label>165. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13262956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6360 class=n-a></a>Patel MR, Mahaffey KW, Garg J, <i> et al.</i>: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. <i>N Engl J Med.</i> 2011; <b>365</b>(10): 883–91. <a target=xrefwindow id=d28076e6371 href="http://www.ncbi.nlm.nih.gov/pubmed/21830957">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6374 href="http://dx.doi.org/10.1056/NEJMoa1009638">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13262956">F1000 Recommendation</a></span></li><li><a name=ref-166 class=n-a></a><span class=label>166. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718181700"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6387 class=n-a></a>Giugliano RP, Ruff CT, Braunwald E, <i> et al.</i>: Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med.</i> 2013; <b>369</b>(22): 2093–104. <a target=xrefwindow id=d28076e6398 href="http://www.ncbi.nlm.nih.gov/pubmed/24251359">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6401 href="http://dx.doi.org/10.1056/NEJMoa1310907">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718181700">F1000 Recommendation</a></span></li><li><a name=ref-167 class=n-a></a><span class=label>167. </span>&nbsp;<span class=citation><a name=d28076e6414 class=n-a></a>Weitz JI, Connolly SJ, Patel I, <i> et al.</i>: Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. <i>Thromb Haemost.</i> 2010; <b>104</b>(3): 633–41. <a target=xrefwindow id=d28076e6425 href="http://www.ncbi.nlm.nih.gov/pubmed/20694273">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6428 href="http://dx.doi.org/10.1160/TH10-01-0066">Publisher Full Text </a></span></li><li><a name=ref-168 class=n-a></a><span class=label>168. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725579799"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6438 class=n-a></a>Pollack CV Jr, Reilly PA, Eikelboom J, <i> et al.</i>: Idarucizumab for Dabigatran Reversal. <i>N Engl J Med.</i> 2015; <b>373</b>(6): 511–20. <a target=xrefwindow id=d28076e6449 href="http://www.ncbi.nlm.nih.gov/pubmed/26095746">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6452 href="http://dx.doi.org/10.1056/NEJMoa1502000">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725579799">F1000 Recommendation</a></span></li><li><a name=ref-169 class=n-a></a><span class=label>169. </span>&nbsp;<span class=citation><a name=d28076e6465 class=n-a></a>Lip GY, Nieuwlaat R, Pisters R, <i> et al.</i>: Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. <i>Chest.</i> 2010; <b>137</b>(2): 263–72. <a target=xrefwindow id=d28076e6476 href="http://www.ncbi.nlm.nih.gov/pubmed/19762550">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6479 href="http://dx.doi.org/10.1378/chest.09-1584">Publisher Full Text </a></span></li><li><a name=ref-170 class=n-a></a><span class=label>170. </span>&nbsp;<span class=citation><a name=d28076e6488 class=n-a></a>Lip GY, Frison L, Halperin JL, <i> et al.</i>: Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort. <i>Stroke.</i> 2010; <b>41</b>(12): 2731–8. <a target=xrefwindow id=d28076e6499 href="http://www.ncbi.nlm.nih.gov/pubmed/20966417">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6502 href="http://dx.doi.org/10.1161/STROKEAHA.110.590257">Publisher Full Text </a></span></li><li><a name=ref-171 class=n-a></a><span class=label>171. </span>&nbsp;<span class=citation><a name=d28076e6511 class=n-a></a>Gage BF, Waterman AD, Shannon W, <i> et al.</i>: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. <i>JAMA.</i> 2001; <b>285</b>(22): 2864–70. <a target=xrefwindow id=d28076e6522 href="http://www.ncbi.nlm.nih.gov/pubmed/11401607">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6525 href="http://dx.doi.org/10.1001/jama.285.22.2864">Publisher Full Text </a></span></li><li><a name=ref-172 class=n-a></a><span class=label>172. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718304415"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6534 class=n-a></a>Pisters R, Lane DA, Nieuwlaat R, <i> et al.</i>: A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. <i>Chest.</i> 2010; <b>138</b>(5): 1093–100. <a target=xrefwindow id=d28076e6545 href="http://www.ncbi.nlm.nih.gov/pubmed/20299623">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6548 href="http://dx.doi.org/10.1378/chest.10-0134">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718304415">F1000 Recommendation</a></span></li><li><a name=ref-173 class=n-a></a><span class=label>173. </span>&nbsp;<span class=citation><a name=d28076e6561 class=n-a></a>Rothwell PM, Eliasziw M, Gutnikov SA, <i> et al.</i>: Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. <i>Lancet.</i> 2003; <b>361</b>(9352): 107–16. <a target=xrefwindow id=d28076e6572 href="http://www.ncbi.nlm.nih.gov/pubmed/12531577">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6575 href="http://dx.doi.org/10.1016/S0140-6736(03)12228-3">Publisher Full Text </a></span></li><li><a name=ref-174 class=n-a></a><span class=label>174. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718371046"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6585 class=n-a></a>Kernan WN, Ovbiagele B, Black HR, <i> et al.</i>: Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke.</i> 2014; <b>45</b>(7): 2160–236. <a target=xrefwindow id=d28076e6596 href="http://www.ncbi.nlm.nih.gov/pubmed/24788967">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6599 href="http://dx.doi.org/10.1161/STR.0000000000000024">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718371046">F1000 Recommendation</a></span></li><li><a name=ref-175 class=n-a></a><span class=label>175. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/3636963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6612 class=n-a></a>Brott TG, Hobson RW 2nd, Howard G, <i> et al.</i>: Stenting versus endarterectomy for treatment of carotid-artery stenosis. <i>N Engl J Med.</i> 2010; <b>363</b>(1): 11–23. <a target=xrefwindow id=d28076e6623 href="http://www.ncbi.nlm.nih.gov/pubmed/20505173">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6626 href="http://dx.doi.org/10.1056/NEJMoa0912321">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6630 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2932446">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/3636963">F1000 Recommendation</a></span></li><li><a name=ref-176 class=n-a></a><span class=label>176. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726874821"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6643 class=n-a></a>Brott TG, Howard G, Roubin GS: Long-Term Results of Stenting Versus Endarterectomy for Carotid-Artery Stenosis. <i>J Vasc Surg.</i> 2016; <b>64</b>(2): 535–6. <a target=xrefwindow id=d28076e6651 href="http://www.ncbi.nlm.nih.gov/pubmed/27763277">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6654 href="http://dx.doi.org/10.1016/j.jvs.2016.06.056">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726874821">F1000 Recommendation</a></span></li><li><a name=ref-177 class=n-a></a><span class=label>177. </span>&nbsp;<span class=citation><a name=d28076e6667 class=n-a></a>Mantese VA, Timaran CH, Chiu D, <i> et al.</i>: The Carotid Revascularization Endarterectomy versus Stenting Trial (CREST): stenting versus carotid endarterectomy for carotid disease. <i>Stroke.</i> 2010; <b>41</b>(10 Suppl): S31–4. <a target=xrefwindow id=d28076e6678 href="http://www.ncbi.nlm.nih.gov/pubmed/20876500">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6681 href="http://dx.doi.org/10.1161/STROKEAHA.110.595330">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6685 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3058352">Free Full Text </a></span></li><li><a name=ref-178 class=n-a></a><span class=label>178. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718113565"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6694 class=n-a></a>Rothwell PM, Eliasziw M, Gutnikov SA, <i> et al.</i>: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. <i>Lancet.</i> 2004; <b>363</b>(9413): 915–24. <a target=xrefwindow id=d28076e6705 href="http://www.ncbi.nlm.nih.gov/pubmed/15043958">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6708 href="http://dx.doi.org/10.1016/S0140-6736(04)15785-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718113565">F1000 Recommendation</a></span></li><li><a name=ref-179 class=n-a></a><span class=label>179. </span>&nbsp;<span class=citation><a name=d28076e6721 class=n-a></a>Chastain HD, Campbell MS, Iyer S, <i> et al.</i>: Extracranial vertebral artery stent placement: in-hospital and follow-up results. <i>J Neurosurg.</i> 1999; <b>91</b>(4): 547–52. <a target=xrefwindow id=d28076e6732 href="http://www.ncbi.nlm.nih.gov/pubmed/10507373">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6735 href="http://dx.doi.org/10.3171/jns.1999.91.4.0547">Publisher Full Text </a></span></li><li><a name=ref-180 class=n-a></a><span class=label>180. </span>&nbsp;<span class=citation><a name=d28076e6745 class=n-a></a>Jenkins JS, White CJ, Ramee SR, <i> et al.</i>: Vertebral artery stenting. <i>Catheter Cardiovasc Interv.</i> 2001; <b>54</b>(1): 1–5. <a target=xrefwindow id=d28076e6756 href="http://www.ncbi.nlm.nih.gov/pubmed/11553939">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6759 href="http://dx.doi.org/10.1002/ccd.1228">Publisher Full Text </a></span></li><li><a name=ref-181 class=n-a></a><span class=label>181. </span>&nbsp;<span class=citation><a name=d28076e6768 class=n-a></a>Sun X, Ma N, Wang B, <i> et al.</i>: The long term results of vertebral artery ostium stenting in a single center. <i>J Neurointerv Surg.</i> 2015; <b>7</b>(12): 888–91. <a target=xrefwindow id=d28076e6779 href="http://www.ncbi.nlm.nih.gov/pubmed/25332411">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6782 href="http://dx.doi.org/10.1136/neurintsurg-2014-011356">Publisher Full Text </a></span></li><li><a name=ref-182 class=n-a></a><span class=label>182. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/13306963"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6791 class=n-a></a>Chimowitz MI, Lynn MJ, Derdeyn CP, <i> et al.</i>: Stenting versus aggressive medical therapy for intracranial arterial stenosis. <i>N Engl J Med.</i> 2011; <b>365</b>(11): 993–1003. <a target=xrefwindow id=d28076e6802 href="http://www.ncbi.nlm.nih.gov/pubmed/21899409">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6805 href="http://dx.doi.org/10.1056/NEJMoa1105335">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6809 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3552515">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/13306963">F1000 Recommendation</a></span></li><li><a name=ref-183 class=n-a></a><span class=label>183. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718157964"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6822 class=n-a></a>Derdeyn CP, Chimowitz MI, Lynn MJ, <i> et al.</i>: Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. <i>Lancet.</i> 2014; <b>383</b>(9914): 333–41. <a target=xrefwindow id=d28076e6833 href="http://www.ncbi.nlm.nih.gov/pubmed/24168957">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6836 href="http://dx.doi.org/10.1016/S0140-6736(13)62038-3">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6840 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3971471">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718157964">F1000 Recommendation</a></span></li><li><a name=ref-184 class=n-a></a><span class=label>184. </span>&nbsp;<span class=citation><a name=d28076e6853 class=n-a></a>Marks MP: Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)? <i>Stroke.</i> 2012; <b>43</b>(2): 580–4. <a target=xrefwindow id=d28076e6861 href="http://www.ncbi.nlm.nih.gov/pubmed/22246690">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6864 href="http://dx.doi.org/10.1161/STROKEAHA.111.645507">Publisher Full Text </a></span></li><li><a name=ref-185 class=n-a></a><span class=label>185. </span>&nbsp;<span class=citation><a name=d28076e6873 class=n-a></a>Qureshi AI: Interpretation and implications of the prematurely terminated Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in the Intracranial Stenosis (SAMMPRIS) trial. <i>Neurosurgery.</i> 2012; <b>70</b>(1): E264–8. <a target=xrefwindow id=d28076e6881 href="http://www.ncbi.nlm.nih.gov/pubmed/21964627">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6884 href="http://dx.doi.org/10.1227/NEU.0b013e318239f318">Publisher Full Text </a></span></li><li><a name=ref-186 class=n-a></a><span class=label>186. </span>&nbsp;<span class=citation><a name=d28076e6894 class=n-a></a>Rahme RJ, Aoun SG, Batjer HH, <i> et al.</i>: SAMMPRIS: end of intracranial stenting for atherosclerosis or back to the drawing board? <i>Neurosurgery.</i> 2011; <b>69</b>(6): N16–8. <a target=xrefwindow id=d28076e6905 href="http://www.ncbi.nlm.nih.gov/pubmed/22067345">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6908 href="http://dx.doi.org/10.1227/01.neu.0000407920.96189.cc">Publisher Full Text </a></span></li><li><a name=ref-187 class=n-a></a><span class=label>187. </span>&nbsp;<span class=citation><a name=d28076e6917 class=n-a></a>Ringer AJ, Khalessi AA, Mocco J, <i> et al.</i>: Intervention for intracranial atherosclerosis after SAMMPRIS. <i>World Neurosurg.</i> 2012; <b>78</b>(5): 409–12. <a target=xrefwindow id=d28076e6928 href="http://www.ncbi.nlm.nih.gov/pubmed/22819755">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6931 href="http://dx.doi.org/10.1016/j.wneu.2012.07.009">Publisher Full Text </a></span></li><li><a name=ref-188 class=n-a></a><span class=label>188. </span>&nbsp;<span class=citation><a name=d28076e6940 class=n-a></a>Miao Z: Intracranial Angioplasty and Stenting before and after SAMMPRIS: "From Simple to Complex Strategy - The Chinese Experience". <i>Front Neurol.</i> 2014; <b>5</b>: 129. <a target=xrefwindow id=d28076e6948 href="http://www.ncbi.nlm.nih.gov/pubmed/25071714">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6951 href="http://dx.doi.org/10.3389/fneur.2014.00129">Publisher Full Text </a> | <a target=xrefwindow id=d28076e6954 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4095563">Free Full Text </a></span></li><li><a name=ref-189 class=n-a></a><span class=label>189. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732010921"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6963 class=n-a></a>Chen PS, Cheng CL, Kao Yang YH, <i> et al.</i>: Statin Adherence After Ischemic Stroke or Transient Ischemic Attack Is Associated With Clinical Outcome. <i>Circ J.</i> 2016; <b>80</b>(3): 731–7. <a target=xrefwindow id=d28076e6974 href="http://www.ncbi.nlm.nih.gov/pubmed/26742588">PubMed Abstract </a> | <a target=xrefwindow id=d28076e6977 href="http://dx.doi.org/10.1253/circj.CJ-15-0753">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732010921">F1000 Recommendation</a></span></li><li><a name=ref-190 class=n-a></a><span class=label>190. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727425126"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e6990 class=n-a></a>Fang J, Wang E, Wang W, <i> et al.</i>: The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. <i>Intern Emerg Med.</i> 2017; <b>12</b>(5): 679–87. <a target=xrefwindow id=d28076e7001 href="http://www.ncbi.nlm.nih.gov/pubmed/28303440">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7004 href="http://dx.doi.org/10.1007/s11739-017-1650-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727425126">F1000 Recommendation</a></span></li><li><a name=ref-191 class=n-a></a><span class=label>191. </span>&nbsp;<span class=citation><a name=d28076e7017 class=n-a></a>Merwick Á, Albers GW, Arsava EM, <i> et al.</i>: Reduction in early stroke risk in carotid stenosis with transient ischemic attack associated with statin treatment. <i>Stroke.</i> 2013; <b>44</b>(10): 2814–20. <a target=xrefwindow id=d28076e7028 href="http://www.ncbi.nlm.nih.gov/pubmed/23908061">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7031 href="http://dx.doi.org/10.1161/STROKEAHA.113.001576">Publisher Full Text </a> | <a target=xrefwindow id=d28076e7035 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3871879">Free Full Text </a></span></li><li><a name=ref-192 class=n-a></a><span class=label>192. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725390590"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7045 class=n-a></a>Robinson JG, Farnier M, Krempf M, <i> et al.</i>: Efficacy and safety of alirocumab in reducing lipids and cardiovascular events. <i>N Engl J Med.</i> 2015; <b>372</b>(16): 1489–99. <a target=xrefwindow id=d28076e7056 href="http://www.ncbi.nlm.nih.gov/pubmed/25773378">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7059 href="http://dx.doi.org/10.1056/NEJMoa1501031">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725390590">F1000 Recommendation</a></span></li><li><a name=ref-193 class=n-a></a><span class=label>193. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725390576"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7072 class=n-a></a>Sabatine MS, Giugliano RP, Wiviott SD, <i> et al.</i>: Efficacy and safety of evolocumab in reducing lipids and cardiovascular events. <i>N Engl J Med.</i> 2015; <b>372</b>(16): 1500–9. <a target=xrefwindow id=d28076e7083 href="http://www.ncbi.nlm.nih.gov/pubmed/25773607">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7086 href="http://dx.doi.org/10.1056/NEJMoa1500858">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725390576">F1000 Recommendation</a></span></li><li><a name=ref-194 class=n-a></a><span class=label>194. </span>&nbsp;<span class=citation><a name=d28076e7099 class=n-a></a>Abboud S, Karhunen PJ, Lütjohann D, <i> et al.</i>: Proprotein convertase subtilisin/kexin type 9 (PCSK9) gene is a risk factor of large-vessel atherosclerosis stroke. <i>PLoS One.</i> 2007; <b>2</b>(10): e1043. <a target=xrefwindow id=d28076e7110 href="http://www.ncbi.nlm.nih.gov/pubmed/17940607">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7113 href="http://dx.doi.org/10.1371/journal.pone.0001043">Publisher Full Text </a> | <a target=xrefwindow id=d28076e7117 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2002510">Free Full Text </a></span></li><li><a name=ref-195 class=n-a></a><span class=label>195. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726014687"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7126 class=n-a></a>Au A, Griffiths LR, Cheng KK, <i> et al.</i>: The Influence of <i>OLR1</i> and <i>PCSK9</i> Gene Polymorphisms on Ischemic Stroke: Evidence from a Meta-Analysis. <i>Sci Rep.</i> 2015; <b>5</b>: 18224. <a target=xrefwindow id=d28076e7144 href="http://www.ncbi.nlm.nih.gov/pubmed/26666837">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7147 href="http://dx.doi.org/10.1038/srep18224">Publisher Full Text </a> | <a target=xrefwindow id=d28076e7150 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4678327">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726014687">F1000 Recommendation</a></span></li><li><a name=ref-196 class=n-a></a><span class=label>196. </span>&nbsp;<span class=citation><a name=d28076e7163 class=n-a></a>Castilla-Guerra L, Fernández-Moreno MC, Rico-Corral MA: Cholesterol and stroke: Roll of PCSK9 inhibitors. <i>Neurologia.</i> 2017; pii: S0213-4853(17)30173-1. <a target=xrefwindow id=d28076e7168 href="http://www.ncbi.nlm.nih.gov/pubmed/28549755">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7171 href="http://dx.doi.org/10.1016/j.nrl.2017.03.009">Publisher Full Text </a></span></li><li><a name=ref-197 class=n-a></a><span class=label>197. </span>&nbsp;<span class=citation><a name=d28076e7180 class=n-a></a>Han D, Ma J, Zhang X, <i> et al.</i>: Correlation of PCSK9 gene polymorphism with cerebral ischemic stroke in Xinjiang Han and Uygur populations. <i>Med Sci Monit.</i> 2014; <b>20</b>: 1758–67. <a target=xrefwindow id=d28076e7191 href="http://www.ncbi.nlm.nih.gov/pubmed/25266949">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7194 href="http://dx.doi.org/10.12659/MSM.892091">Publisher Full Text </a> | <a target=xrefwindow id=d28076e7198 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4189717">Free Full Text </a></span></li><li><a name=ref-198 class=n-a></a><span class=label>198. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726504589"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7208 class=n-a></a>Milionis H, Barkas F, Ntaios G, <i> et al.</i>: Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: Effect on stroke risk. <i>Eur J Intern Med.</i> 2016; <b>34</b>: 54–7. <a target=xrefwindow id=d28076e7219 href="http://www.ncbi.nlm.nih.gov/pubmed/27363304">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7222 href="http://dx.doi.org/10.1016/j.ejim.2016.06.023">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726504589">F1000 Recommendation</a></span></li><li><a name=ref-199 class=n-a></a><span class=label>199. </span>&nbsp;<span class=citation><a name=d28076e7235 class=n-a></a>Slimani A, Harira Y, Trabelsi I, <i> et al.</i>: Effect of E670G Polymorphism in <i>PCSK9</i> Gene on the Risk and Severity of Coronary Heart Disease and Ischemic Stroke in a Tunisian Cohort. <i>J Mol Neurosci.</i> 2014; <b>53</b>(2): 150–7. <a target=xrefwindow id=d28076e7249 href="http://www.ncbi.nlm.nih.gov/pubmed/24599757">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7253 href="http://dx.doi.org/10.1007/s12031-014-0238-2">Publisher Full Text </a></span></li><li><a name=ref-200 class=n-a></a><span class=label>200. </span>&nbsp;<span class=citation><a name=d28076e7262 class=n-a></a>Chen W, Pan Y, Jing J, <i> et al.</i>: Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus. <i>J Am Heart Assoc.</i> 2017; <b>6</b>(6): pii: e005446. <a target=xrefwindow id=d28076e7273 href="http://www.ncbi.nlm.nih.gov/pubmed/28572281">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7276 href="http://dx.doi.org/10.1161/JAHA.116.005446">Publisher Full Text </a></span></li><li><a name=ref-201 class=n-a></a><span class=label>201. </span>&nbsp;<span class=citation><a name=d28076e7285 class=n-a></a>Xu J, Viscoli CM, Ford GA, <i> et al.</i>: A Diagnostic Score for Insulin Resistance in Nondiabetic Patients with Ischemic Stroke or Transient Ischemic Attack. <i>J Stroke Cerebrovasc Dis.</i> 2016; <b>25</b>(7): 1705–12. <a target=xrefwindow id=d28076e7296 href="http://www.ncbi.nlm.nih.gov/pubmed/27080156">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7299 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2016.03.043">Publisher Full Text </a></span></li><li><a name=ref-202 class=n-a></a><span class=label>202. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727409108"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7308 class=n-a></a>Lin Y, Wang A, Li J, <i> et al.</i>: Impact of Glycemic Control on Efficacy of Clopidogrel in Transient Ischemic Attack or Minor Stroke Patients With <i>CYP2C19</i> Genetic Variants. <i>Stroke.</i> 2017; <b>48</b>(4): 998–1004. <a target=xrefwindow id=d28076e7322 href="http://www.ncbi.nlm.nih.gov/pubmed/28289237">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7326 href="http://dx.doi.org/10.1161/STROKEAHA.116.016463">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727409108">F1000 Recommendation</a></span></li><li><a name=ref-203 class=n-a></a><span class=label>203. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726151168"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d28076e7339 class=n-a></a>Kernan WN, Viscoli CM, Furie KL, <i> et al.</i>: Pioglitazone after Ischemic Stroke or Transient Ischemic Attack. <i>N Engl J Med.</i> 2016; <b>374</b>(14): 1321–31. <a target=xrefwindow id=d28076e7350 href="http://www.ncbi.nlm.nih.gov/pubmed/26886418">PubMed Abstract </a> | <a target=xrefwindow id=d28076e7353 href="http://dx.doi.org/10.1056/NEJMoa1506930">Publisher Full Text </a> | <a target=xrefwindow id=d28076e7357 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4887756">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726151168">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1893/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1893/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Neurology, Loyola University Medical Center, Maywood, IL, USA<br/> <p> <div class=margin-bottom> Camilo R. Gomez <br/> <span>Roles: </span> Conceptualization, Data Curation, Supervision, Validation, Writing – Original Draft Preparation, Writing – Review & Editing </div> <div class=margin-bottom> Michael J. Schneck <br/> <span>Roles: </span> Conceptualization, Methodology, Visualization, Writing – Review & Editing </div> <div class=margin-bottom> Jose&#769; Biller <br/> <span>Roles: </span> Conceptualization, Data Curation, Methodology, Project Administration, Validation, Visualization, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-1893/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 26 Oct 2017, 6:1893 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12358.1">https://doi.org/10.12688/f1000research.12358.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Gomez CR <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13381 data-id=12358 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12358.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-1893/v1/pdf?article_uuid=0b1c78c0-c4b8-4789-9552-69972f167c9b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12358.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Gomez CR, Schneck MJ and Biller J. Recent advances in the management of transient ischemic attacks [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):1893 (<a href="https://doi.org/10.12688/f1000research.12358.1" target=_blank>https://doi.org/10.12688/f1000research.12358.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12358 id=mobile-track-article-signin-12358 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12358?target=/articles/6-1893/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13381 /> <input name=articleId type=hidden value=12358 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Pierre Amarenco</strong>, Bichat University Hospital, France </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Peter Rothwell</strong>, Nuffield Department of Clinical Neurosciences, University of Oxford, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 26 Oct 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-1893/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-1893/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27260-27153></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27261-27154></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-1893/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>26 Oct 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Pierre Amarenco</strong>, Bichat University Hospital, France </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Peter Rothwell</strong>, Nuffield Department of Clinical Neurosciences, University of Oxford, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-1893/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-1893/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in the management of transient...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-1893/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-1893/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-1893/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Gomez CR et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-1893/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-1893",
            templates : {
                twitter : "Recent advances in the management of transient ischemic attacks. Gomez CR et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-1893/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in the management of transient ischemic attacks", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in the management of transient ischemic attacks", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12358/13381")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13381");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "27153": 0,
                           "27154": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "8435a22b-d81c-4ccf-acd7-1e84adfc4058";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1893.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1893.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-1893.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-1893.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-1893.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>